Dawn, light at night and the clock:Impact on human alertness, performance and physiology by van de Werken, Maan
  
 University of Groningen
Dawn, light at night and the clock
van de Werken, Maan
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2013
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
van de Werken, M. (2013). Dawn, light at night and the clock: Impact on human alertness, performance and
physiology. Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Dawn, Light at night anD the CLoCk
Impact on Human Alertness, Performance and Physiology 
The research in this thesis was carried out at the Department of 
Chronobiology, University of Groningen, The Netherlands. 
The research was supported by the University of Groningen, the 6th 
Framework Project EUCLOCK (No. 018741), Philips Lighting, Philips 
Consumer Lifestyle, Bühlmann laboratories and STW (No. 12187). 
This thesis was printed with financial support from the University of 
Groningen Library and the Graduate School of Science Groningen.
Lay-out and figures: Stichting Kalamiteit, Dokkum
Cover design: Pico van de Werken
Printed by: Gildeprint Drukkerijen, Enschede
ISBN: 978-90-367-6653-1 
ISBN: 978-90-367-6654-8  (electronic version)
RIJKSUNIVERSITEIT GRONINGEN
Dawn, Light at night anD the CLoCk
impact on human alertness, 
Performance and Physiology
Proefschrift
ter verkrijging van het doctoraat in de
Wiskunde en Natuurwetenschappen
aan de Rijksuniversiteit Groningen
op gezag van de
Rector Magnificus, dr. E. Sterken,
in het openbaar te verdedigen op
vrijdag 6 december 2013
om 14.30 uur
door
Maan van de werken
geboren op 14 januari 1978
te Dantumadeel
 Promotor :  Prof. dr. D. G. M. Beersma 
 Copromotor :  Dr. M. C. M. Gordijn 
 Beoordelingscommissie :  Prof. dr. S. A. Brown 
    Prof. dr. A. Johnson 
    Prof. dr. E. J. W. van Someren 









 Table of Contents
ChaPteR 1 INTRODUCTION AND DISCUSSION 
ChaPteR 2 SHORT-WAVELENGTH ATTENUATED POLYCHROMATIC  
 WHITE LIGHT DURING WORK AT NIGHT: LIMITED   
 MELATONIN SUPPRESSION WITHOUT SUBSTANTIAL 
 DECLINE OF ALERTNESS 
ChaPteR 3 MELATONIN SUPPRESSION BY LIGHT IS NEGATIVELY 
 CORRELATED TO CREB SIGNALING IN FIBROBLASTS; 
 IMPLICATIONS FOR SEASONAL AFFECTIVE DISORDER
ChaPteR 4 EFFECTS OF ARTIFICIAL DAWN ON SLEEP INTERTIA, 
 SKIN TEMPERATURE, AND THE AWAKENING 
 CORTISOL RESPONSE
ChaPteR 5 THE BIOLOGICAL CLOCK MODULATES THE HUMAN 








Maan van de Werken
Chapter 1
10
Selection pressures for a clock
Our Solar System was formed about 4.6 billion years ago, with our planet 
Earth approximately 4.5 billion years ago. The Earth is the third nearest 
planet to the sun and it rotates around the sun in a close to circular orbit. 
One rotation of the Earth around the sun makes one calendar year of about 
365 days, and one rotation around its axis makes a day of 24 hours. For over 4 
billion years, the most predictable changes on Earth are the transitions from 
day to night and from night to day. In its early history, the Earth was exposed 
to high dosages of light, including damaging UV light since no ozone had 
been formed in the atmosphere (Cockell & Horneck, 2001). The first forms of 
life on Earth made use of light to generate biomass (through photosynthesis) 
and dealt with this UV-challenge by evolving adequate protective and repair 
mechanisms. Both the advantageous and the detrimental effects of light created 
selection pressures to regulate biological activities in response to light and 
darkness; ‘masking’, but also a selective pressure to anticipate these exquisitely 
predictable changes; ‘timing’. This latter selective advantage has resulted in 
the development of biological clocks, molecular clockworks able to keep time 
independent of external cues, allowing to anticipate predictable/cyclic changes 
in the environment. This selective advantage is demonstrated experimentally in 
cyanobacteria, one of the first organisms that evolved on Earth. Mutations in 
the KaiC gene generate bacteria with deviating intrinsic periods of their clock, 
and these mutants outcompete wild-types in mixed cultures when the extrinsic 
light-dark cycle matches the intrinsic period of the mutant (Ouyang et al., 
1998). Under constant light conditions an intact molecular clock even has an 
apparent selective disadvantage (Woelfle et al., 2004).  
Clocks 
Biological clocks are found in organisms as diverse as cyanobacteria, fruit flies, 
rodents and humans (Dunlap, 1999). The basic properties that make a clock are 
the ability to self-sustain rhythmicity under constant conditions, and the ability 
to become entrained to relevant external cues, ‘Zeitgebers’, to synchronize 
the internal timing mechanism with the external cycle. While the clock needs 
to be sensitive to the relevant Zeitgeber, it should not be sensitive to other 
influences, such as environmental temperature (Pittendrigh, 1960; Roenneberg 
& Merrow, 2005). This insensitivity to temperature fluctuations is a special 
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feature for clock cells since normally reaction rates of molecular processes 
speed up with higher temperatures. This has to be avoided in clocks to avoid 
clock speed being affected by fluctuations in temperature of the organism 
itself or its environment. Initial investigations into the molecular machinery 
that underlies these abilities have pointed to the importance of transcription 
translation feedback loops (TTFLs) (Dunlap, 1999). These loops consist 
of the transcription and translation of a ‘clock’ protein that negatively feeds 
back on its own transcription via interlocked loops with other ‘clock’ proteins 
(Lakin-Thomas, 2006). The delay in this feedback is fundamental to generate 
the rhythmic expression of such a ‘clock’ protein. In many model organisms 
mutations in ‘clock’ proteins result in deviations in rhythmic behaviour and 
TTFLs were therefore considered to be responsible for the molecular basis 
of keeping time (Baylies et al., 1987; Van der Horst et al., 1999). This view 
changed when cyanobacteria were shown to exhibit rhythmic KaiC (a ‘clock’ 
protein) phosphorylation in the dark when transcription is absent (Tomita 
et al., 2005) and when three isolated proteins (plus ATP) from cyanobacteria 
(KaiA, KaiB and KaiC) were shown to generate rhythmic oscillations in KaiC 
phosphorylation in a test tube (Nakajima et al., 2005). This demonstrated 
that TTFLs are not always necessary for rhythmic behaviour. Recently, self-
sustained rhythmic behaviour was also demonstrated to occur for the protein 
peroxiredoxin in human red blood cells that lack a nucleus and therefore do not 
perform transcription (O’Neill & Reddy, 2011).
On the level of the whole organism the ability to self-sustain rhythmicity with 
a period close to 24 h (circa-dian) can be observed in for example rhythmic 
behavioural and physiological changes when they are kept void of the external 
cues. These cues entrain the endogenous rhythm of an organism to the 
external 24 h cycle and in their absence, for example in constant darkness, 
the endogenous rhythm is revealed and free-runs (Chapter 5; Aschoff, 1965). 
Explants of cells or tissues also readily show self-sustained rhythms in a 
dish (Stokkan et al., 2001; Welsh et al., 2004; Yamazaki et al., 2000). These 
rhythms are especially clear in explants from the suprachiasmatic nucleus 
(SCN) (Bos & Mirmiran, 1990; Yamaguchi et al., 2003), an organ located 
in the brain specialized to keep time. The SCN acts as a master clock and 
synchronizes other brain areas and peripheral tissues to regulate physiology and 
behaviour according to time (Buijs & Kalsbeek, 2001; Dibner et al., 2010). Via 
entrainment of the endogenously rhythm of the SCN to external cues the SCN 
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can predict external time. Hereby the SCN offers mammals to live their lives 
highly tuned to external time and this allows them to do the ‘right thing at the 
right time’. The transitions between night and day are the most stable reference 
points for the time of day. Hence, it is not surprising that light is the main 
Zeitgeber for many organisms, including humans.
Light entering the body
There are several ways via which light can affect an organism. The physical 
properties of light can be damaging (UV damaging DNA and molecules) or 
its energy can be utilized, for example to transform useful compounds (for 
example vitamin D formation), or to produce biomass (photosynthesis). 
Alternatively light can be perceived, and used for vision or as a direct 
environmental cue (non-image forming responses to light). In perception, 
light enters an organism’s neuronal circuitry once it hits photoreceptors 
that ‘translate’ photonic exposure into neuronal action potentials. In the 
retina of the eye, specialized cells are present that perceive and integrate light 
information via the expression of specialized photopigments. Rods, cones 
and a subset of retinal ganglion cells all express photopigments that capture 
photons and transform the light signal into neuronal action potentials. 
The photopigments in these cells are sensitive to different parts of the light 
spectrum (Hatori & Panda, 2010). A specific group of retinal ganglion 
cells is directly photoreceptive due to their expression of the photopigment 
melanopsin (Bailes & Lucas, 2010; Berson et al., 2002; Hattar et al., 2002), 
and these cells are especially relevant for circadian biology. These so-called 
intrinsically photosensitive retinal ganglion cells (ipRGCs) are most sensitive 
to the blue part of the light spectrum, and they also receive input from rods 
and cones (Hatori & Panda, 2010). IpRGCs are the main photoreceptive 
cells needed for photoentrainment, since photoentrainment is lost after 
selective lesion of these cells (Hatori et al., 2008) and also after knockout of 
the melanopsin gene (Hattar et al., 2003). IpRGCs project to the SCN via 
the rentinohypothalamic tract (Hannibal, 2002), that follows the optic nerves 
and innervates the SCN at the optic chiasm (where the optic nerves cross). 
Neurotransmitters released at the end of this tract directly activate SCN 
cells (Hannibal, 2002). In this way, the SCN is entrained daily to local time. 
Electrical activity of the SCN peaks during the day, in both day- and night- 
active animals (Challet, 2007). The SCN entrains, gates, stimulates and/or 
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inhibits other brain areas, which in turn affect other parts of the body (Dibner 
et al., 2010). 
Direct effects of light
Besides the SCN playing an important role in orchestrating synchrony within 
bodily processes, it also gates, in a phase dependent manner, the effects of 
light on specific brain and peripheral areas. Light can only directly affect 
physiological systems if there are neuronal connections with light receptors, 
often but not always guided via the SCN. Only certain parts of, and processes 
in, the body are directly influenced by light (e.g. masking). Light for example 
directly inhibits the nightly production of melatonin in the pineal gland 
(Chapter 1; Brainard et al., 2001; Lewy et al., 1980; Thapan et al., 2001), but 
it also directly stimulates the production of cortisol in the adrenal gland at the 
beginning of the subjective day/active period (Scheer & Buijs, 1999). Bodily 
processes that are influenced directly by light are subject to relatively high 
fluctuations in stimulatory and/or inhibiting input (possibly dependent upon 
circadian phase), resulting from the presence and intensity of light exposure. 
Especially cells that show relatively low signal transduction strength (see 
Individual Differences section below) are predicted to be influenced strongly 
by light, rendering individuals with low excitability cells more susceptible to 
fluctuations in light exposure (Chapter 3). 
Light not only influences physiology, but also has direct effects on behaviour. 
Especially short-wavelength (‘blue’) light has been shown to increase alertness 
(Revell et al., 2006) and subjective activation (Chapter 2) and to decrease 
subjective sleepiness (Cajochen et al., 2005). Another example of a direct 
effect of light is the accelerated dissipation of sleep inertia by artificial dawn 
simulation; light exposure gradually increasing in the morning before waking 
up (Chapter 4). Although morning light commonly induces phase advances, 
no phase-shifting response to artificial dawn was detected in a complementary 
study performed by Giménez et al. (2010). The dawn simulation effects 
(Chapter 4; Giménez et al. 2010) are thus likely attributable to a direct 
activating effect by light.
Effects of light differ between species, for example different species occupy 
different temporal niches. Accordingly, light either signals the animal’s active 
or inactive period, in diurnal and nocturnal animals respectively (Challet, 
2007). The effects of light on physiology and behaviour therefore depend 
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on the species and its neuronal organization (Castillo-Ruiz & Nunez, 2007; 
Kalsbeek et al., 2012). Most experimental studies in circadian biology in 
mammals are performed with nocturnal rodents. The responses to light are 
often extrapolated to diurnal mammals as if these responses are simply opposite 
to the responses reported in these nocturnal models. This is based on the 
possibly misleading assumption that the physiology regulating differences 
between night- and day- active animals only changes the sign of the response, 
emphasizing the importance of translating knowledge about the effects of light 
and circadian biology obtained in animal studies to humans.
Light at ‘unnatural’ times in humans
In a natural situation, only daylight activates the SCN resulting in a clear 
representation of daytime. Since the discovery of electricity, artificial lighting 
provides light at unexpected phases of the clock and also allows humans to be 
active during the dark phase. In most cases light is used at times corresponding 
to personal preferred wake time. Therefore most people do not choose to 
expose themselves to light or to be active in the middle of the night because 
at that time they prefer to sleep. Consequently, the use of artificial light at 
‘unnatural’ times is relatively limited and this leaves circadian physiology and 
behaviour relatively unaffected. Yet, the use of artificial light does create a 
discrepancy with natural photoperiodic cues that regulate seasonal rhythmicity. 
Short winter days are elongated by the use of artificial lighting more so than 
long summer days (Giménez et al., 2013). Other differences between timing 
of light exposure and activity in comparison to internal circadian phase result 
from flying east or west, also termed jet lag, and from working at night. In the 
Western World many people travel using transcontinental flights, and about 
15-30% of the working population in the industrialized countries regularly 
perform work at night (Boivin et al., 2007; Haus & Smolensky, 2006). 
health and the clock
Shift work and repeated travel between time zones have been associated with 
increased risk of disease. Shift work is associated with higher risks of cancer 
(Schernhammer & Schulmeister, 2004; Straif et al., 2007; Viswanathan 
& Schernhammer, 2009) with increased risk of breast cancer in nurses 
(Schernhammer et al., 2001), obesity (Karlsson et al., 2001), diabetes 
(Karlsson et al., 2001; Morikawa et al., 2005), cardiovascular disease (Bøggild 
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& Knutsson, 1999; Hublin et al., 2010; Knutsson et al., 1986; Vyas et al., 
2012), and depression (Glass & Fujimoto, 1994; Scott et al., 1997). Also 
pilots and cabin personnel suffer from increased risks of cancer (Rafnsson et 
al., 2000; 2001; Reynolds et al., 2002). The association of this risk with the 
number of time zones travelled suggests the involvement of circadian rhythm 
disturbances in addition to the possible involvement of cosmic radiation 
and life style (Rafnsson et al., 2000). Light and activity out of phase with 
the clock and repeated re-entrainment, shifting of the clock, all have been 
proposed as possible mechanisms underlying these higher risks of disease 
and mortality. Animal studies indeed suggest a causal involvement of light at 
night and repeated shifting of the clock. Light at night increases the growth 
rate of tumours (Blask et al., 2005; Cos et al., 2006) and forced shift work 
results in obesity, but only when feeding is also allowed outside of the natural 
active phase (Arble et al., 2010; Salgado-Delgado et al., 2010). Repeated 
phase-shifting accelerates mortality in mice (Davidson et al., 2006; Penev et 
al., 1998). Interestingly, even the association with depression-like behaviour 
is apparent as a consequence of light provided at night in a diurnal rodent: 
the Nile grass rat (Fonken et al., 2012). The hypotheses suggesting that phase 
shifting or light at night underlie the higher risks of disease found in shift work 
and flight personnel are distinct but are also not mutually exclusive. On a more 
mechanistic level phase-shifting may cause circadian dysregulation between 
the rhythm of the SCN and peripheral rhythms in other tissues, possibly 
contributing to the observed higher risks of disease (Haus & Smolensky, 2006). 
On the other hand, phase shifts will be associated with light (and activity) 
at the beginning and/or at the end of the dark phase and hence the two are 
difficult to disentangle. 
Melatonin
One hormone thought to be responsible for conferring the rhythm of the 
SCN to the rest of the body is melatonin. Melatonin is often referred to as ‘the 
hands of the clock’ and it shows a highly robust intrinsic rhythm in humans 
(Chapter 5). Administration of melatonin can entrain activity rhythms in 
humans and rodents. Blind individuals can be entrained by timed dosages of 
melatonin (Lockley et al., 2000; Sack et al., 2000) and rodents and monkeys 
in constant conditions can also be entrained by melatonin administration 
(Cassone et al., 1986; Masuda & Zhdanova, 2010). Peripheral tissues express 
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melatonin receptors (Ekmekcioglu, 2006) and are influenced or entrained by 
melatonin accordingly (Pévet & Challet, 2011). Although it is also sometimes 
referred to as ‘the sleep hormone’, this is based on the coincidence of melatonin 
release and sleep in diurnal species, such as humans. Causal associations with 
feelings of sleepiness and lower vigilance were only reported during daytime 
after melatonin administration likely resulting in blood concentrations in a 
pharmacological range (Cajochen et al., 1996; Graw et al., 2001; Kräuchi et 
al., 2006). In this thesis we do not find any associations between physiological 
melatonin concentrations and subjective ratings of activation or sleepiness at 
night (Chapter 2), contrary to results of Cajochen et al. (2000), but in line with 
the conclusions in Rüger et al. (2005). Yet, melatonin administration in the 
evening does reduce time needed to fall asleep and it increases sleep duration 
as concluded from a meta-analysis, but only slightly so, by 4 minutes and 13 
minutes respectively (Brzezinski et al., 2005).
Melatonin is produced in the pineal gland in the brain and its rhythmic 
synthesis is regulated directly by the SCN. During daytime the SCN inhibits 
melatonin production by inhibiting the firing rate of the paraventricular 
nucleus (PVN) that is located in the hypothalamus. At night the SCN 
relieves its inhibition of the PVN, which then stimulates the pineal gland via 
a multi-synaptic pathway. At the end of this pathway the neurotransmitter 
noradrenaline is released, which activates β1-adrenoceptors of the pineal cells 
(Simonneaux & Ribelayga, 2003). Binding of noradrenaline to these G protein-
coupled receptors activates the adenylyl cyclase (AC) – cyclic-AMP (cAMP) 
– protein kinase A (PKA) signalling pathway leading to phosphorylation of 
Arylalkylamine N-acetyltransferase (AANAT), the rate limiting enzyme in 
melatonin synthesis. Phosphorylated AANAT forms a regulatory complex 
with 14-3-3- proteins, which activates the AANAT enzyme but also 
prevents its degradation via proteasomal proteolysis (Klein, 2006). AANAT 
phosphorylation is a crucial step in the synthesis of melatonin and it is reduced 
in response to light exposure. Light suppresses nightly melatonin production 
in a dose- and duration- dependent manner (Brainard et al., 2001; Chang et al., 
2012; Thapan et al., 2001). Light inhibits, via the SCN, the stimulatory input 
of the PVN most likely at the level of the pineal gland (Chapter 3; Kalsbeek 
et al., 1999). Reduced noradrenergic stimulation of β1-adrenoceptors of the 
pineal cells will decrease AC – cAMP – PKA stimulation and increase AANAT 
proteasomal proteolytic degradation.  The drop in melatonin synthesis upon 
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light exposure is almost immediately measurable in saliva. 
Light information responsible for this suppression is transduced via ipRGCs 
to the SCN and hence melatonin is most effectively suppressed with light of 
relatively short wavelengths (blue light) (Chapter 2). Melatonin suppression 
thus provides a direct response to light at night and probably phase shifts 
peripheral rhythms, but also alters the daily melatonin profile, a cue of 
photoperiod that is implicated in the regulation of seasonal rhythmicity 
(Arendt, 1998). It is not surprising that this important hormone in circadian 
regulation has been hypothesized to be involved in the negative effects of light 
at night (Flynn-Evans et al., 2009; Schernhammer & Schulmeister, 2004; Straif 
et al., 2007; Viswanathan & Schernhammer, 2009). Experimentally, melatonin 
has been shown to repress growth of human breast cancer xenografts (Blask et 
al., 2005) suggesting direct protective roles of melatonin. These include anti-
proliferative effects (Blask, 1984; Blask et al., 1999), antioxidant effects (Blask 
et al., 2002; Brzezinski, 1997), immunostimulatory effects (Brzezinski, 1997; 
Panzer & Viljoen, 1997) and modulation of the expression of the tumour 
suppressor gene p53 (Mediavilla et al., 1999). Melatonin may also play a 
crucial role in the associations of shift-work with diabetes, hypothesized to be 
generated by disrupted rhythms in peripheral tissues (Staels, 2006). A possible 
mechanism could be direct disruption of insulin secretion rhythms, as isolated 
pancreatic tissue of rats can be shifted by melatonin (Peschke & Peschke, 
1998). Knockout of the melatonin receptor in mice induces insulin resistance 
(Contreras-Alcantara et al., 2010; Mühlbauer et al., 2009). Therefore the health 
of shift workers may benefit when melatonin suppression by light at night is 
prevented. In this thesis the use of short-wavelength attenuated polychromatic 
white light (‘yellow light’) in a simulated shift work setting is shown to result 
in very limited melatonin suppression, as measured in saliva and urine, without 
substantial declines in alertness or performance (Chapter 2). 
Cortisol
Another hormone that shows pronounced circadian rhythmicity is cortisol. In 
humans, cortisol starts to rise during the second half of the night and highest 
levels are reached in the early morning where after a slow decline results in 
lowest levels in the evening (Edwards et al., 2001; Wüst et al., 2000). Waking up 
in particular results in large increases in cortisol. This is termed the awakening 
cortisol response and is characterized by a pronounced peak in production 
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typically 30-40 min after waking up, which returns back to baseline levels after 
approximately 60-90 min (Chapter 4; Edwards et al., 2001; Hucklebridge 
et al., 2005; Pruessner et al., 1997; Wüst et al., 2000). Cortisol is released in 
response to stressors and prepares the body to either fight or flee the stressor. 
For example stress stimulates gluconeogenesis, the release of glucose from the 
liver and increases blood pressure (Kemeny, 2003). The awakening cortisol 
response is therefore also hypothesized to contribute to the dissipation of sleep 
inertia, the period of reduced alertness and reduced consciousness, directly after 
waking up (Clow et al., 2010). Yet, in Chapter 4 it is reported that an alarm 
clock, which simulates dawn by slowly increasing light intensity, reduced sleep 
inertia complaints, without a clear effect on cortisol. Also, subjective ratings of 
activation appeared to be negatively associated with absolute levels of cortisol, 
possibly also arguing against a direct relationship between the awakening 
cortisol response and sleep inertia dissipation. 
Cortisol levels do not only increase upon awakening and in response to stress, 
but also readily in response to food intake and light exposure (Gibson et al., 
1999; Gonzalez-Bono et al., 2002; Scheer & Buijs, 1999). Negative effects 
of long-term stress are implicated to increase risk of disease and cortisol 
specifically has been linked to obesity (Rosmond et al., 1998), cardiovascular 
disease (Girod & Brotman, 2004; Whitworth et al., 2005), and depression 
(Cowen, 2010). Interestingly these health problems are also more experienced 
by shift workers (Bøggild & Knutsson, 1999; Glass & Fujimoto, 1994; 
Hublin et al., 2010; Karlsson et al., 2001; Knutsson et al., 1986; Morikawa et 
al., 2005; Scott et al., 1997; Vyas et al., 2012). Shift workers have also been 
shown to have higher long-term levels of cortisol, as, for instance, shown from 
hair sampling (Manenschijn et al., 2011). Abnormally low or high levels of 
cortisol can also impact on cognitive functioning, possibly reducing adequate 
decision making (Belanoff et al., 2001). The relationship between cortisol and 
cognitive functioning may be one of the factors contributing to the higher rate 
of occupational accidents in shift work (Folkard & Lombardi, 2006; Suzuki 
et al., 2004) and major accidents have been linked to faulty decisions in a shift 
work setting, for example the Chernobyl and 3-mile island nuclear disasters, 
the Exxon Valdez oil tanker grounding and the explosion of the space shuttle 
Challenger (Harrington, 2001). 
Cortisol is released by the adrenal glands upon activation by 
adrenocorticotropic hormone (ACTH) produced in the anterior pituitary 
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upon stimulation by the PVN via corticotrophin releasing hormone (CRH). 
This system comprises the hypothalamic-pituitary-adrenal axis (HPA) 
(Kalsbeek et al., 2012). The circadian rhythm in cortisol is generated by dual 
control of the adrenal cortex (Engeland & Arnhold, 2005). Direct neuronal 
innervation of the adrenals by the SCN generates a circadian rhythm in the 
sensitivity of the adrenal to ACTH, thereby orchestrating rhythmic cortisol 
release. ACTH is also rhythmically released and this has been interpreted as a 
direct action of the central clock to produce a set amount of ACTH (Cascio 
et al., 1987; Engeland & Arnhold, 2005). However, the study in Chapter 5 
suggests that this response is likely due to the central clock modulating the 
sensitivity to release ACTH upon stimulation by CRH, or to sensitivity to 
produce CRH in the first place. In that study (Chapter 5) we find using a 
forced desynchrony protocol, in which clock and masking components can 
be separated for their effects on behaviour and physiology, cortisol levels are 
predicted closely by a multiplication model of the masking and circadian 
component. This model fits with physiological regulation of cortisol release 
via modulation of sensitivity by the clock to produce cortisol in response to 
a stimulus. This means that the cortisol response to a certain stimulus will 
drastically vary in magnitude dependent on circadian phase. Shift workers 
operating at the peak of the circadian rhythm in stress sensitivity are predicted 
to be subjected to abnormally high levels of cortisol. This may generate future 
health risks and may reduce performance. Health and performance of shift 
workers may therefore improve when stress is reduced at times when the clock 
produces high stress sensitivity (at 8:42 sensitivity to produce cortisol is highest 
for average chronotypes, Chapter 5).
Skin temperature
Another profound change throughout the body is the distribution of heat 
within the body resulting from dynamic changes in core versus proximal and 
distal skin temperature. Core temperature is low at night and is preceded by 
vasodilation in hands and feet resulting in higher distal skin temperatures 
(Kräuchi et al., 2000). This process has a strong circadian component (Gradisar 
& Lack, 2004). These changes can be characterized using a distal-to-proximal 
skin temperature gradient (DPG) which is correlated to subjective sleepiness 
(Kräuchi et al., 1997; 2004; Rubinstein & Sessler, 1990), subjective activation 
(Chapter 2) and vigilance (Raymann & Van Someren, 2007). Preceding 
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nocturnal sleep, distal skin temperatures increase (Kräuchi et al., 1999; 2000) 
and this relationship has a causal component. Time needed to fall asleep 
is reduced when extremities are experimentally warmed (Raymann et al., 
2005; 2007). Melatonin is suggested to regulate changes in vasodilation and 
indeed melatonin administration results in increases in skin temperature and 
decreases in core temperature (Kräuchi et al., 1997; 2006). Contrary to these 
findings, differences in melatonin measured during a night under dim and 
under full-spectrum light were not related to skin temperature differences 
between these nights (Chapter 2), questioning direct causal involvement of 
melatonin in regulating the level of vasodilation resulting in changes in skin 
temperature. A possible explanation for these contradictory results could be 
that the experiment described in Chapter 2 was performed at night while the 
experiments by Kräuchi et al. (1997, 2006) were performed during daytime. 
In the process of waking up, skin temperatures decline and during this period 
of sleep inertia it is linked to the dissipation of sleepiness and decrements in 
activation (Chapter 4; Kräuchi et al., 2004). Interestingly in this thesis strong 
and consistent relationships between skin temperature and subjective ratings 
of activation and sleepiness are reported, both in the morning during waking 
up (Chapter 4) and while staying awake at night (Chapter 2). This in contrast 
with the lack of associations between subjective activation and sleepiness 
with melatonin and between subjective sleepiness and cortisol (Chapter 2; 
Chapter 4). This may suggest that changes in blood flow dynamics are among 
the strongest determinants of activation and sleepiness (Van Someren, 2000). 
Indeed, skin temperature is also likely causally involved since cooling of the skin 
increases vigilance (Fronczek et al., 2008). The concordant experimental effect 
of artificial dawn simulation on skin temperature and subjective ratings of 
activation and sleepiness (Chapter 4) also suggest such a causal relationship. 
individual differences
Examples of between individual differences in biology are manifold, as they 
are also in chronobiology. One of the most characteristic examples is the 
preferred timing of sleep and activity in the day. Some individuals prefer to get 
up and go to bed early, whereas others are late types and prefer to stay up late 
and to sleep in (Horne & Östberg, 1976; Roenneberg et al., 2003) and these 
differences have a heritable component (Klei et al., 2005; Vink et al., 2001). 
Late chronotype is associated with higher risk of depressive mood (Hidalgo et 
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al., 2009), cardiovascular disease and diabetes (Merikanto et al., 2013). Shifts 
in activity patterns may contribute to these relationships, either directly or 
indirectly via effects on sleep. These shifts in activity patterns can arise due 
to social or work obligations because early types stay up too late or late types 
get up too early with respect to their internal phase. This creates a difference 
in activity patterns between free days and workdays, termed social jetlag. The 
degree of social jetlag is linked to smoking habits (Wittmann et al., 2006) and 
obesity (Roenneberg et al., 2012). In a sense, individuals suffering from social 
jetlag may be viewed as undergoing repeated shift work and may also suffer 
from the associated health problems, and hence may also benefit from possible 
interventions that may improve health of shift workers.  
Another striking level of individual variation was encountered in the study 
presented in Chapter 3. Melatonin suppression differed markedly between 
individuals in response to a similar level of light stimulation. Because 
melatonin is hypothesized to play a role in the health deficits of shift workers, 
a molecular basis of these individual differences was sought. From part of the 
subjects enrolled in Chapter 2, we also collected skin fibroblasts to test the 
sensitivity of a part of the molecular signalling cascade that is also involved 
in melatonin suppression, namely the AC – cAMP – PKA pathway. Light 
exposure at night reduces noradrenergic stimulation of β1-adrenoceptors 
of the pineal cells (Simonneaux & Ribelayga, 2003), causing a reduced 
stimulation of the intra-pineal cell AC – cAMP – PKA pathway, resulting 
in reduced melatonin synthesis. This latter intracellular signalling pathway 
was stimulated in fibroblasts obtained from subjects in order to determine 
the degree of excitability of this pathway. In the same subjects, the degree of 
melatonin suppression was investigated in response to light. Intriguingly in 
vivo melatonin suppression showed a strong negative correlation with in vitro 
cellular excitability suggesting that part of the between-individual differences in 
melatonin suppression is caused by differences in either AC or PKA (Chapter 
3). In addition, these results show that fibroblasts can be used as a model for 
processes regulated in the human brain, such as melatonin suppression. 
A prediction on individual sensitivity for melatonin suppression would be 
highly relevant within the context of shift work and health.
improving human performance and health around the clock
Knowledge about circadian biology and the effects of light on the body opens 
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exciting avenues to improve human performance and health. In this thesis we 
show that light stimulation in the morning, through dawn simulation, reduces 
sleep inertia complaints (Chapter 4). Many people suffer from sleep inertia, 
reduced alertness and consciousness immediately after waking up, which may 
last for over an hour. Melatonin suppression by light has been implicated in 
the development of health deficits related to shift work. By using knowledge 
about the spectral sensitivity of the non-image forming light sensitive system 
providing input to the circadian system, health of shift workers may improve. In 
Chapter 2, we show that the use of short-wavelength attenuated polychromatic 
white light during work at night allowed for an undisturbed melatonin profile 
without large repercussions for performance, although the relatively high distal 
skin temperature may be a physiological indication that vigilance might be 
affected negatively. Individuals involved in night or shift work, likely differ in 
their susceptibility to the negative health effects of light at unnatural times. 
For example, individuals with low melatonin suppression under a considerable 
amount of lighting may be less susceptible. Insight in the mechanisms 
underlying variation in melatonin suppression may help shift workers and may 
even have implications for the treatment of individuals suffering from seasonal 
affective disorder (Chapter 3). By linking in vivo melatonin suppression to 
the excitability of a specific pathway in fibroblasts obtained from the same 
subjects, the first steps are taken in understanding the physiology underlying 
variation in human melatonin suppression. This knowledge may facilitate a 
better understanding of the molecular background of individual differences 
in the sensitivity to light, or even to detrimental effects of working night 
shifts in general. Not only light at night, but also performing activities at an 
‘unnatural’ circadian phase may result in abnormal physiological responses 
that may underlie health problems prevalent in shift workers. Using a forced 
desynchrony protocol we show that cortisol production, a marker of stress, has 
a strong circadian component. Most importantly this circadian component 
influences cortisol production in a multiplicative fashion. Therefore activities 
such as eating or psychological stress are predicted to result in extremely low 
or extremely high levels of cortisol, dependent on circadian phase (Chapter 5). 
Dysregulation of cortisol levels may also underlie part of the health problems 
incurred by shift workers as cortisol is implicated in many health problems 
similar to those that shift workers suffer from. Shift workers may benefit from 
limiting stress during times when their circadian stress sensitivity is highest. 
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Together these results indicate that making relatively small changes to the shift 
worker’s environment has the potential for considerable gains in their health.
Benefits from a biological clock are especially reaped when living in tune with 
the external light dark cycle. However, social and/or work related obligations 
may cause misalignment of our internal timing with our actual behaviour and 
exposure to light. Investigating under which conditions individual preferences 
and actual behaviour are ideally combined is becoming more and more 
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Exposure to light at night increases alertness, but light at night (especially 
short-wavelength light) also disrupts nocturnal physiology. Such disruption is 
thought to underlie medical problems for which shift workers have increased 
risk. In 33 male subjects we investigated whether short-wavelength attenuated 
polychromatic white light (< 530 nm filtered out), at night preserves dim light 
melatonin levels and whether it induces similar skin temperature, alertness, and 
performance levels as under full-spectrum light. All 33 subjects participated in 
random order during three nights (at least 1 wk apart) either under dim light 
(3 lux), short-wavelength attenuated polychromatic white light (193 lux), or 
full-spectrum light (256 lux). Hourly saliva samples for melatonin analysis 
were collected along with continuous measurements of skin temperature. 
Subjective sleepiness and activation were assessed via repeated questionnaires 
and performance was assessed by the accuracy and speed of an addition task. 
Our results show that short-wavelength attenuated polychromatic white light 
only marginally (6%) suppressed salivary melatonin. Average distal-to-proximal 
skin temperature gradient (DPG) and its pattern over time remained similar 
under short-wavelength attenuated polychromatic white light compared with 
dim light. Subjects performed equally well on an addition task under short-
wavelength attenuated polychromatic white light compared with full-spectrum 
light. Although subjective ratings of activation were lower under short-
wavelength attenuated polychromatic white light compared with full-spectrum 
light, subjective sleepiness was not increased. Short-wavelength attenuated 
polychromatic white light at night has some advantages over bright light. It 
hardly suppresses melatonin concentrations, whereas performance is similar 
to the bright light condition. Yet, alertness is slightly reduced as compared 
with bright light, and DPG shows similarity to the dim light condition, which 
is a physiological sign of reduced alertness. Short-wavelength attenuated 
polychromatic white light might therefore not be advisable in work settings 
that require high levels of alertness.
Short-wavelength attenuated light during work at night
27
Introduction
In industrialized countries, about 15-30% of the working population is involved 
in some kind of permanent night and rotating shift work (Boivin et al., 2007; 
Haus & Smolensky, 2006). This means that many people are exposed to light 
and to darkness at atypical biological times because their work and subsequent 
sleep are not synchronized with the natural light-dark cycle. Sleeping and 
working out of phase with the body’s circadian rhythms for longer periods can 
cause (chronic) fatigue and affect performance and cognitive functions (Costa, 
1996; Härmä et al., 2002; Wright et al., 2006). Moreover shift work has been 
associated with health problems including cardiovascular disease, impaired 
glucose and lipid metabolism, type 2 diabetes, gastrointestinal discomfort 
such as stomach ache or diarrhea, reproductive difficulties, and cancer 
(Haus & Smolensky, 2006; Jasser et al., 2006; Mahoney, 2010; Morikawa 
et al., 2005; Rüger & Scheer, 2009; Straif et al., 2007; Viswanathan & 
Schernhammer, 2009).
The medical problems encountered by shift workers are thought to result 
from disturbed physiological rhythms, circadian misalignment and sleep dept 
(Rajaratnam & Arendt, 2001; Rüger & Scheer, 2009; Scheer et al., 2009; Van 
Cauter et al., 1997). Being exposed to light at night shifts the phase of the 
central master clock in the brain (suprachiasmatic nucleus [SCN]), which 
is responsible for synchronizing endogenous circadian rhythms, such as the 
melatonin rhythm, and the rhythm of peripheral clocks. Light, and especially 
short-wavelength light, the blue part of the light spectrum, entrains circadian 
rhythms in humans (Lockley et al., 2003; Revell & Eastman, 2005; Rüger 
et al., 2012; Warman et al., 2003), but also exerts an acute suppressing effect 
upon melatonin production (Brainard et al., 2001; Thapan et al., 2001). In 
addition, short-wavelength light suppresses sleepiness (Cajochen et al., 2005) 
and increases alertness (Revell et al., 2006) effectively, which is beneficial for 
performance at night (Chellappa et al., 2011). These specific effects of short-
wavelength light are attributed to non-visual photoreceptive input by specific 
retinal ganglion cells towards the SCN (Gooley et al., 2003; Hattar et al., 
2002). These cells express a specific photopigment, melanopsin, which has a 
peak absorbance around 480 nm with an approximate upper boundary at 540 
nm (Dacey et al., 2005; Walker et al., 2008).
Long-term suppression of melatonin production is thought to play an 
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important role in increased prevalence of cancer in shift workers (Flynn-
Evans et al., 2009; Schernhammer & Schulmeister, 2004; Straif et al., 2007; 
Viswanathan & Schernhammer, 2009). Direct protective roles of melatonin 
against cancer development have been proposed: antiproliferative effects (Blask, 
1984; Blask et al., 1999), antioxidant effects (Blask et al., 2002; Brzezinski, 
1997), immunostimulatory effects (Brzezinski, 1997; Panzer & Viljoen, 
1997), and modulation of the expression of the tumour suppressor gene p53 
(Mediavilla et al., 1999). Shift work has also been associated with increased 
prevalence of diabetes and the metabolic syndrome (Karlsson et al., 2001; 
Morikawa et al., 2005). This is thought to be caused by disrupted physiological 
rhythms in peripheral tissues (Staels, 2006). Melatonin may play a crucial role 
here as well, for melatonin has been shown to shift insulin secretion rhythms of 
isolated pancreatic tissue of rats (Peschke & Peschke, 1998).
In our 24-h society it becomes more and more important to unravel the 
biological mechanisms that are involved in the development of health problems 
in shift workers and to investigate different countermeasures. One of such 
measures, the use of short-wavelength attenuated polychromatic white light, 
was investigated in the present study. From an economical point of view, it 
seems beneficial to expose shift workers to full-spectrum light at night to 
increase alertness and improve performance at night. On the other hand, if 
working under full-spectrum light at night is detrimental for health on the long 
term, alternatives such as short-wavelength attenuated polychromatic white 
light should be subject of investigation. To assess the magnitude of possible 
decrements in performance under short-wavelength attenuated polychromatic 
white light, we included an addition task and measures of subjective sleepiness, 
subjective activation, and skin temperature during prolonged wakefulness 
while working at night. Skin temperature is linked to sleepiness (Kräuchi et al., 
1997, 2004) and vigilance (Raymann & Van Someren, 2007). Sleep initiation 
is preceded by a rise in distal skin temperature (Kräuchi et al., 1999, 2000) and 
experimentally warming extremities reduces the time needed to fall asleep in 
healthy subjects (Raymann et al., 2005, 2007). During night sleep, distal skin 
temperatures remain high and core body temperature drops (Kräuchi et al., 
2000) and this process has a strong circadian component (Gradisar & Lack, 
2004). Upon waking up, skin temperature declines and during this stage lower 
skin temperatures are linked to decreased sleepiness and increased activation 
(Kräuchi et al., 2004; Van de Werken et al., 2010). Indeed cooling instead of 
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warming of the skin increased vigilance in narcolepsy patients (Fronczek et al., 
2008). The physiological functions of skin temperature dynamics during day 
and night, other than those associated with sleep, are not well known compared 
with our understanding of the actions of melatonin. However a disturbance in 
the regular dynamics of thermal regulation may also have negative effects on 
health, unknown to us thus far.
In the present study we studied 33 male subjects in three conditions in three 
separate nights (at least 1 wk apart in randomized order): a dim light condition, 
a short-wavelength attenuated polychromatic white light condition, and a full-
spectrum light condition. We investigated the effects of these light conditions 
on subjective ratings of sleepiness and activation, performance on an addition 
task, melatonin levels, and the distal-to-proximal skin temperature gradient 
(DPG) (Kräuchi et al., 2000; Rubinstein & Sessler, 1990). 
Materials and Methods
Subject Characteristics
Subjects (33 healthy males, mean age [±SD] 22.6 ± 2.2 yr) did not have sleep 
disorders (Pittsburgh Sleep Quality Index < 6; Buysse et al., 1989), somatic 
diseases, depressed mood (Beck Depression Inventory-II < 8; Beck et al., 1996, 
2002), chronic diseases, colour blindness (Ishihara test, Clark, 1924), or visual 
impairment (assessed by general health questionnaire). Subjects did not use 
medication (assessed by general health questionnaire). Neither did they work 
in night shifts or travelled across more than one time zone respectively 3 and 1 
mo preceding the study. Subjects had an average chronotype for their gender 
and age (mean midsleep on free days [±SD] 5:45 h ± 43 min, with a mean sleep 
onset [±SD] at 01:24 h ± 58 min and a mean sleep offset [±SD] at 10:05 h ± 
49 min, rated on the Munich Chronotype Questionnaire; Roenneberg et al., 
2003). Subjects did not report excessive intake of caffeinated drinks (average 
cups a day [±SD] 2 ± 2) or alcohol (average glasses a week [±SD] 8 ± 5), were 
non-smoking and did not use drugs (assessed by general health questionnaire). 
The study protocol was approved by the Medical Ethics Committee of the 
University Medical Center of Groningen, The Netherlands, and conformed 
to international ethical standards (Portaluppi et al., 2008). All subjects 





In this paper the results of two similar studies were combined. These studies 
differed in a single aspect: in Study I subjects stayed together with other 
participants in one room and in Study II all subjects stayed in individual rooms. 
The studies consisted of three nights from 21:00 till 7:00 h in the laboratory, 
with a minimum of 1 wk between successive measurements (see Figure 1). 
The first study in which 17 subjects participated was carried out between 
October 10 and November 22, 2008, and the second study in which 16 subjects 
participated was carried out between June 19 and August 7, 2010. Only in 
Study I the experiment continued the subsequent day at home until 23:00 h, 
during which urine was collected for 6-sulfatoxymelatonin (aMT6s) analysis. 
During the first 2 h of each night, subjects stayed in dim light (< 5 lux). In the 
first hour (21:00 – 22:00 h), subjects were oriented to study the protocol (data 
not included, except for salivary melatonin concentration). During the second 
hour (22:00 – 23:00 h), baseline data were collected. In random order, from 
23:00 till 7:00 h subjects stayed in one of the following three conditions: (1) 
dim light (horizontal light intensity [±SD] 1 ± 1 lux, vertical light intensity 
at the level of the eye [±SD] 3 ± 2 lux); (2) short-wavelength attenuated 
polychromatic white light (horizontal light intensity [±SD] 438 ± 101 lux, 
vertical light intensity at the level of the eye [±SD] 193 ± 108 lux; short-
wavelength [< 530 nm] reducing foil [heat shrinkable tubing; WLF-NR400-
4-SP; Tyco Electronics, UK] melted around a Philips TL-D 36W/830, aimed 
to reduce non-visual photoreception via melanopsin, total irradiance from 420 
to 530 nm = 0.0 W/m2); or (3) full-spectrum light (horizontal light intensity 
[±SD] 625 ± 151 lux, vertical light intensity at the level of the eye [±SD] 256 
± 131 lux, total irradiance from 420 to 530 nm = 0.14 W/m2; Philips TL-D 
36W/830); see Figure 2 for the spectral composition of the lights. Subjects 
were placed in the same location in the room in all three conditions to reduce 
within individual variation in light intensities and stayed seated behind their 
computers as far as possible. Subjects were not allowed to sleep at any time 
during the experiment. Hourly snacks of 100 calories and 130 mL water (room 
temperature) were supplied. Computer screens and dim lights were covered 
with a colour filter (E-colour +, 105 Orange; Rosco Laboratories, London, 
UK) to decrease short-wavelength light transmission.
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In the laboratory Urine collection at home (only part of Study I)
Dim        Dim light (< 5 lux)  
Dim        polychromatic white light (193 lux)





21:00 23:00 7:00 15:00 23:00
Figure 1: Overview of the experimental design; for the experimental details refer to the Experimental 
Design section (Methods). 
Figure 2: Spectral power distribution. Short-wavelength attenuated 
polychromatic white light (thick line) was obtained by melting a yellow 
filter (see Materials and Methods for specifications) on top of a 830 TL 
tube (3000K), which was also used in the full-spectrum light condition 
(thin line).
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Each hour (from 21:30 till 6:30 h), saliva samples were collected using 
cotton swabs (Salivettes; Sarstedt, Etten-Leur, The Netherlands). Melatonin 
concentration was assessed by radioimmunoassay (RK-DSM; Bühlmann 
Laboratories, Alere Health, Tilburg, The Netherlands). Each sample was 
analysed once and all samples from each individual were analysed together 
within the same assay. Analytical sensitivity: 0.2 pg mL-1; intra- and inter-assay 
coefficients of variability: 7.8% (mean 14.5 pg mL-1) and 13.8% (mean 17.6 
pg mL-1), respectively. Two baseline measurements were carried out in each 
condition in dim light (at 21:30 and 22:30 h). 
Urinary 6-Sulfatoxymelatonin (aMT6s)
Just before the experimental light condition was set in the first study (at 23:00 h),
subjects were asked to empty their bladder. From here on, total 24-h urine 
production was collected at three 8-h intervals. Urine from the first interval 
(23:00 – 7:00 h) was collected during the experiment in the laboratory. Urine 
from the second (7:00 – 15:00 h) and third (15:00 – 23:00 h) intervals was 
collected at home. aMT6s concentration was assessed by enzyme-linked 
immunosorbent assay (ELISA; EK-M6S; Bühlmann Laboratories, Alere 
Health, Tilburg, The Netherlands). Each sample from one individual was 
analysed within the same assay. Analytical sensitivity: 0.14 ng mL-1; intra- and 
inter-assay coefficients of variability: 10.6% (mean 25.3 ng mL-1) and 21.2% 
(mean 26.1 ng mL-1), respectively. Total aMT6s excretion was calculated by 
multiplying concentration and volume.
Distal-to-Proximal Skin Temperature Gradient
Skin temperatures were recorded throughout the night at a rate of one sample 
per minute. Recording ended immediately after the last testing periods at 
7:00 h. Skin temperature was measured using Ibuttons (DS1922L; Maxim 
Integrated Products, Sunnyvale, CA, USA; resolution 0.0625 °C; for further 
technical details and validation of the use of Ibuttons to measure skin 
temperature, see Van Marken Lichtenbelt et al., 2006) that were placed on the 
base of left and right middle fingers (distal skin temperature) and left and right 
infraclavicular regions (proximal skin temperature). The DPG was calculated as 
distal minus proximal skin temperature.
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Subjective Ratings of Sleepiness and Activation
Subjective ratings of sleepiness (Karolinska Sleepiness Scale; Åkerstedt & 
Gillberg, 1990) and activation (two factors of the Thayer adjective checklist; 
Thayer, 1967) were determined hourly. 
Addition Task
Every hour, subjects made as many correct additions as possible within a 3-min 
interval using a custom-made computer test. All additions consisted of two 
random numbers of two digits each.
Statistical analysis
The differences over time of salivary melatonin, urinary aMT6s, subjective 
ratings of sleepiness, activation, and the addition task were tested with a 
repeated-measures analysis of variance (ANOVA) with one within factor (time) 
and one within factor (condition). The percentage of melatonin suppression 
is calculated by comparing the area under the curve in the dim light condition 
with the area under the curve in the short-wavelength attenuated polychromatic 
white light and full-spectrum light condition over the whole night (from 23:30 
till 6:30 h). Percentage of correct additions was tested non-parametrically 
(k related samples) with a Friedman test. Baseline measurements were tested 
separately, to check whether already at this moment a difference could be 
observed between the three conditions. Study was included as a between-
subject factor and was maintained in the model if it contributed significantly 
(either as main effect or in interaction with condition or with condition × 
time), which was only the case for salivary melatonin and subjective activation. 
We detected that in Study I absolute salivary melatonin levels were slightly 
lower than in Study II across the three conditions (P = 0.02). Within the 
analysis on subjective ratings of activation, we detected an interaction between 
study and condition (P = 0.03). These results, also taking into account that in 
exploring the effects of study we carried out multiple tests for which we did not 
correct P values upwards, indicate that there are no strong differences between 
these two data sets that confound our interpretations. 
Skin temperature outliers (defined as quartile + [2 × interquartile range])
were deleted and interpolated. This resulted in data loss at the end of the night 
because data could not be interpolated there, resulting in a maximum of 12-
min data reduction to which all subjects were truncated. For the analysis of 
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the resulting DPG, we used mixed-effect regression analysis using MLwiN 
software (Centre for Multilevel Modelling, Institute of Education, London, 
UK). The analyses take the hierarchical structure of the design into account, in 
our case the temperature measurements i that were nested within participants 
j, once more nested within condition k, and lastly nested within study l (Twisk, 
2003). Because the sampling frequency of skin temperature was high (once per 
minute), we also corrected for auto-correlated residual errors by including an 
auto-correlation function that was optimized manually to fit the data best into 
the models. To control for pseudo-replication optimally, we not only included 
random intercepts but also random coefficients (Schielzeth & Forstmeier, 
2009) for linear time, sqrt(time), condition, and the interactions including 
condition. The following model equation was used to fit the data:
Temperatureijkl = β0jkl + β1j × Conditionijkl + β2j × Linear_timeijkl + β3j × 
 Sqrt(time)ijkl + β4j × Condition × Linear_timeijkl + β5j × 
 Condition × Sqrt(time)ijkl + β6 × Ambient_Temperatureijkl
where β0 represents the model intercept, β1 the deviation from the intercept 
(at 23:00 h) of each condition (Condition), β2 and β3 together represent the 
non-linear time course of temperature during the night (Linear_time indicates 
the time since 23:00 h, Sqrt(time) indicates the square root of linear time), β4 
the effect of condition on the linear component of the time course, β5 the effect 
of condition on the non-linear time component, and β6 the effect of ambient 
temperature during the night. Maximum likelihood was used to estimate the 
regression coefficients of which the statistical significance was evaluated using 
z-tests. To test whether the average DPG across the night differed between 
conditions, we implemented repeated-measures procedures outlined above with 
DPG residuals corrected for room temperature as the dependent variable.
A Pearson correlation was used to show the relationship between the change in 
melatonin and the change in DPG with the change in sleepiness and activation 
between the dim light and short-wavelength attenuated polychromatic 
white light conditions and between the dim light and the full-spectrum light 
conditions. These values were first z-transformed as follows: the difference of 
each individual measurement between conditions (from 23:00 to 6:30 h) was 
first averaged per subject and then averaged for all subjects, the overall average 
was subtracted from the average per subject and then divided by the SD of the 
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overall average for all subjects.
For graphical purposes only, salivary melatonin was normalized to the 
maximum value of the best-fitted melatonin curve (Van Someren & Nagtegaal, 
2007) in the dim light condition, and the number of correct additions were 
normalized as follows: all samples per subject were divided by the average of all 
samples over the dim light condition per subject (indicated by the dotted line 
in the graph) (from 23:00 to 6:00 h) and then multiplied by 100%.
Values are described as average ± SEM. All tests were two tailed with a 0.05 
level of significance. 
Results
Salivary Melatonin
At baseline (21:30 and 22:30 h), before initiating the three light conditions, 
salivary melatonin values were similar (F2,30 = 0.95, non-significant [NS]) 
between conditions. In the dim light and short-wavelength attenuated 
polychromatic white light conditions, melatonin remained high throughout 
the night, whereas within the full-spectrum light condition, melatonin 
was suppressed compared with dim light and short-wavelength attenuated 
polychromatic white light (Figure 3; dim light: F1,31 = 32.69, P < 0.001, short-
wavelength attenuated polychromatic white light: F1,31 = 27.62, P < 0.001; 
interaction with time, dim light: F7,25 = 12.15, P < 0.001, short-wavelength 
attenuated polychromatic white light: F7,25 = 3.13, P < 0.05). Within the short-
wavelength attenuated polychromatic white light condition, melatonin was 
significantly suppressed relative to dim light (F1,31 = 5.27, P < 0.05; interaction 
with time, F7,25 = 1.51, NS), but suppression was small (6 ± 4%) compared with 
the suppression in the full-spectrum light condition (45 ± 6%). 
Urinary 6-Sulfatoxymelatonin (aMt6S)
Melatonin production as measured by aMT6s excretion showed significantly 
different patterns between conditions over the 24-h period (Figure 4; F4,13 
= 10.12, P = 0.001). Post hoc tests revealed that the difference in pattern 
over time was caused by a significantly lower aMT6s concentration in the 
full-spectrum light condition compared with both the dim light and short-
wavelength attenuated polychromatic white light conditions in the interval 
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23:00 – 7:00 h (dim light: F1,16 = 19.47, P < 0.001; short-wavelength 
attenuated polychromatic white light: F1,16 = 39.05, P < 0.001). At the same 
interval, a trend was observed suggesting lowered melatonin in the short-
wavelength attenuated polychromatic white light compared with the dim 
light condition (F1,16 = 4.17, P = 0.06), which fits the salivary melatonin 
data. That the differences in aMT6s concentrations are found only at this first 
interval and not in the second interval, which reflects early morning melatonin 
levels, suggests that the largest differences in melatonin levels between light 
conditions are found in the middle of the night. This pattern fits with the 
salivary melatonin data as well.
Distal-to-Proximal Skin temperature gradient
With respect to DPG, the three conditions did not differ at the start of the 
experiment (P values ≥ 0.5). DPG rose in the dim light and short-wavelength 
Figure 3:  Salivary melatonin concentration. Mean (±SEM) melatonin 
concentration in the dim light (black squares), short-wavelength 
attenuated polychromatic white light (grey circles), and full-spectrum 
light (white circles) conditions (n = 33). 
The first two samples of each condition (at 21:30 and 22:30 h) were 
taken in dim light.
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attenuated polychromatic white light conditions (Figure 5), with a similar 
trajectory over the whole night (β estimate ± error: Condition × Linear_time 
= 0.03 ± 0.17 °C h-1, NS; Condition × Sqrt(time) = -0.12 ± 4.19 °C h-1, NS). 
The rise in DPG was not observed in the full-spectrum light condition. This 
resulted in significantly different trajectories of DPG in the full-spectrum 
light condition compared with the dim light and short-wavelength attenuated 
polychromatic white light conditions (vs. dim light: Condition × Linear_time 
= 0.51 ± 0.17 °C h-1, P < 0.005, Condition × Sqrt(time) = -11.75 ± 4.26 °C h-1, 
P < 0.01; vs. short-wavelength attenuated polychromatic white light: Condition 
× Linear_time = 0.48 ± 0.18 °C h-1, P < 0.01, Condition × Sqrt(time) = 
-11.62 ± 4.59 °C h-1, P < 0.05) and a significantly lower average DPG in the 
experimental night under full-spectrum light (dim light: F1,32 = 15.39, P < 
0.001; short-wavelength attenuated polychromatic white light: F1,32 = 5.30, P < 
0.05) compared with dim light and short-wavelength attenuated polychromatic 
white light (which were not significantly different, F1,32 = 2.27, NS).
Figure 4:  Urinary 6-sulfatoxymelatonin 
(aMT6s). Mean (±SEM) of total 
aMT6s excretion in the dim light (black 
squares), short-wavelength attenuated 
polychromatic white light (grey circles), 
and full-spectrum light (white circles) 
conditions (n = 17) during the experiment 
in the laboratory (first interval: 23:00 – 
7:00 h) and during the subsequent day 
at home where subjects were exposed 
to their own lights (second interval: 
07:00 – 15:00 h and third interval: 15:00 
– 23:00 h). Note that only in Study I the 
experiment continued the subsequent day 
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Subjective Sleepiness and activation
At baseline (22:00 h), subjective sleepiness did not differ significantly between 
conditions (F2,31 = 0.82, NS) nor did subjective activation (F2,30 = 0.42, NS). 
Sleepiness increased significantly during the course of the night (Figure 6A; 
F7,26 = 18.07, P < 0.001), but no significant differences were found between the 
three conditions (condition: F2,31 = 2.77, NS). Sleepiness showed a significantly 
different pattern over time between the three conditions (condition × time: 
F14,19 = 2.73, P < 0.05; this was not solely attributable to the small spike at 3:00 h
in the dim light condition; without these data in the analysis the interaction 
remained significant). Activation decreased significantly during the night (Figure 
6B; F7,25 = 35.94, P < 0.001), with a similar pattern over time between the three 
conditions (F14,18 = 1.95, NS). No significant difference was found between the 
dim light and short-wavelength attenuated polychromatic white light conditions 
Figure 5: Distal-to-proximal skin temperature gradient. Thin lines 
represent the mean (±SEM) DPG values and thick lines represent the 
best fit through the raw data; in dim light (black lines), short-wavelength 
attenuated polychromatic white light (grey lines), and full-spectrum light 
(white lines) conditions (n = 33). Hourly oscillations in all conditions 
are visible and these are attributable to the hourly tests the subjects 
performed (see Methods).
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Figure 6: Subjective sleepiness and activation. (A) Mean (±SEM) 
subjective ratings of sleepiness (Karolinska Sleepiness Scale, 1 = lowest 
and 9 = highest sleepiness) and (B) mean (±SEM) subjective ratings 
of activation (Thayer adjective checklist, 10 = lowest and 40 = highest 
activation) in the dim light (black squares), short-wavelength attenuated 
polychromatic white light (grey circles), and full-spectrum light (white 
circles) conditions (n = 33). Baseline measurements were performed at 
22:00 h in dim light.
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(F1,31 = 1.43, NS). However, both conditions differed significantly from the full-
spectrum light condition (dim light: F1,31 = 5.54, P < 0.05; short-wavelength 
attenuated polychromatic white light: F1,31 = 6.33, P < 0.05).
addition task
During the baseline measurement (22:00 h), no significant differences between 
conditions were found in the number of correct additions obtained during a 
3-min interval by the subjects (dim light: 36 ± 2; short-wavelength attenuated 
polychromatic white light: 37 ± 2; full-spectrum light: 38 ± 2; F2,31 = 0.62, NS) 
nor in the percentages of additions that were correct (dim light: 95%, short-
wavelength attenuated polychromatic white light: 95%, full-spectrum light: 
96%; χ2 = 1.27, NS). During the experimental periods, subjects performed 
equally well in each lighting condition in terms of the fraction of correctly 
made additions (average percentage correct additions, dim light: 96%, short-
wavelength attenuated polychromatic white light: 96%, full-spectrum light: 
Clock time (hh:mm)





























Figure 7: Number of correct additions. Mean (±SEM) number of correct 
additions in the dim light (black squares), short-wavelength attenuated 
polychromatic white light (grey circles), and full-spectrum light (white 
circles) conditions (n = 33). The number of correct additions made during 
a 3-min time interval were normalized within subjects relative to their dim 
light average from 23:00 up to 6:00 h inclusive (indicated by the dotted 
line). Baseline measurements were done at 22:00 h in dim light.
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96%; χ2 = 1.70, NS). The total number of correct additions made (Figure 7) 
was higher in the short-wavelength attenuated polychromatic white light (on 
average 40 ± 2; F1,32 = 18.30, P < 0.001) and in the full-spectrum light (on 
average 40 ± 2; F1,32 = 15.87, P < 0.001) conditions compared with the dim 
light condition (on average 36 ± 2), whereas no significant difference was 
found between the short-wavelength attenuated polychromatic white light and 
full-spectrum light conditions (F1,32 = 0.01, NS). This suggests that subjects 
perform better under full-spectrum light and short-wavelength attenuated 
polychromatic white light conditions because they work faster at a similar 
error rate compared with the dim light condition. Conditions differed in their 
pattern over time (F14,19 = 2.34, P < 0.05), during which the number of correct 
additions on average decreased (time: F7,26 = 6.92, P < 0.001).
Relationships Between Melatonin, DPg, Sleepiness, and activation
The difference in melatonin between the dim light condition and the short-
wavelength attenuated polychromatic white light condition or full-spectrum 
light condition did not correlate with the difference in sleepiness or activation 
between these conditions (dim light vs. short-wavelength attenuated 
polychromatic white light: sleepiness r = 0.094, NS, activation r = -0.185, NS; 
dim vs. full-spectrum light: sleepiness: r = 0.179, NS, activation: r = -0.074, 
NS; see Supplementary Material). The difference in sleepiness or activation 
between the dim light and short-wavelength attenuated polychromatic 
white light conditions did not correlate with the difference in DPG between 
these conditions (sleepiness: r = 0.263, NS; activation: r = -0.045, NS). 
However, between the dim light and full-spectrum light conditions, the 
correlations between the difference in subjective ratings and difference in 
DPG were significant (sleepiness: r = 0.437, P < 0.05; activation: r = -0.401, 
P < 0.05), indicating that with increasing DPG people felt more sleepy and 
less subjectively activated. The degree of melatonin suppression under short-
wavelength attenuated polychromatic white light or full-spectrum light did 
not correlate to the difference of DPG under dim light with short-wavelength 
attenuated polychromatic white light or full-spectrum light (short-wavelength 





This study shows that when healthy male individuals are exposed to short-
wavelength attenuated polychromatic white light at night, both salivary 
melatonin profile and average salivary melatonin concentration are only 
marginally, but significantly, affected (on average 6 ± 4% suppression) 
compared with the same situation in dim light. As expected, a clear suppression 
of melatonin was observed under full-spectrum light (on average 45 ± 6% 
compared with dim light). Similar results were found for urinary aMT6s 
concentration measured in a subsample of our subjects. Two earlier studies 
(Kayumov et al., 2005; Rahman et al., 2011) also found some melatonin 
suppression when short-wavelengths were filtered out, but not significantly so.
This is surprising because both these studies used short-wavelength attenuated 
light conditions that can be predicted to result in higher melatonin suppression 
compared with our study; in the study of Rahman et al. less of the spectrum was 
filtered out (filters used at the level of the eye: 0% transmission < 480 nm)
and higher light intensities were used (439 lux in angle of gaze) than in our 
study (193 lux at the level of the eye) and Kayumov et al. also used higher light 
intensities (800 lux), but with a similar filtering of the spectrum (< 530 nm,
using goggles with filters). With a larger sample size than both these studies 
(33 subjects in the current study vs. 12 and 19 subjects in Rahman et al. 
and Kayumov et al., respectively), we now detect a significant but only 
small suppression of melatonin (6%) under short-wavelength attenuated 
polychromatic white light. This effect could be due to some activation at the 
edge (around 550 nm; see Figure 2) of the action spectrum of melatonin 
suppression (Brainard et al., 2001; Thapan et al., 2001) by the short-wavelength 
attenuated polychromatic white light. This could mean that melanopsin 
expressing retinal ganglion cells are responsible for the suppression of melatonin 
we observe and/or that the visual system of rods and cones is contributing. 
Connections of rods and cones with the intrinsically photosensitive retinal 
ganglion cells (ipRGCs) are presumed to be responsible for rod/cone input 
towards the SCN (Belenky et al., 2003; Hatori & Panda, 2010; Wong et al., 
2007). Indeed at relatively low intensities, ‘green’ light (555 nm) can suppress 
melatonin as effectively as ‘blue’ light (460 nm), but this effect is progressively 
lost with increasing duration of light exposure (measured up to 6.5 h) (Gooley 
et al., 2010). This fits with the melatonin suppression by short-wavelength 
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attenuated polychromatic white light that we observed during the first 4 – 5 h, 
but not at the end of the protocol (Figure 3). That the suppression of melatonin 
in our short-wavelength attenuated polychromatic white light condition 
did not reach the degree of melatonin suppression in the full-spectrum light 
condition as for ‘green’ light in Gooley et al. (2010) suggests that light across 
only a range of wavelengths can elicit this combined response. In support 
of this, high intensity ‘red’ light (630 nm) was not able to induce melatonin 
suppression in humans (Hanifin et al., 2006). Physiologically, this could mean 
that both cones and ipRCGs have to be excited to obtain signal transduction 
towards the SCN, limiting these responses to the wavelengths at which both 
these photoreceptors are excited, namely the ‘blue’ towards ‘green’ light. 
The ‘green’ proportion in the spectrum of the short-wavelength attenuated 
polychromatic white light condition we used (Figure 2) was probably not 
sufficient to elicit this response fully. Possibly illustrative of how small differen-
ces in the amount of ‘blue’ light filtered can effect study outcomes, a study that 
used orange lenses glasses, which filtered out more wavelengths (< 540 nm)
than our study, reported no melatonin suppression compared with a grey 
lenses glasses condition (14 subjects; Sasseville et al., 2006). On average, 
even a slight non-significant increase was found. In this study, even higher 
light intensities (1300 lux at the eye level) were used than the two other 
studies on melatonin suppression under short-wavelength attenuated light 
(Kayumov et al., 2005; Rahman et al., 2011), including our study. The two 
separate studies that were combined in this paper were performed in groups or 
in isolation, and also in different seasons, namely winter and summer. That we 
find across these two studies consistent effects of short-wavelength attenuated 
polychromatic white light strengthens the potential general applicability 
of short-wavelength attenuated polychromatic white light. The degree of 
melatonin suppression in response to full-spectrum light has been shown to 
depend upon prior light history (Hébert et al., 2002; Higuchi et al., 2007; 
Smith et al., 2004). However in comparing the two studies (i.e., seasons) 
included here we do not detect significantly different levels of melatonin 
suppression (no interaction effect of condition × study, or condition × time × 
study, see also the Statistical Analysis section). 
Subjective sleepiness showed the characteristic increase during the night, 
which is the result of increased homeostatic sleep pressure due to prolonged 
wakefulness in combination with a high circadian pressure for sleep at the end 
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of the night (Dijk & Edgar, 1999). Subjects, however, did not feel significantly 
sleepier under dim light or short-wavelength attenuated polychromatic 
white light compared with full-spectrum light. The average full-spectrum 
light intensities (256 lux) that we used are around the inflection point of the 
S-shaped dose-response curve of light intensity against sleepiness (Cajochen 
et al., 2000). Indoors, these light intensities are often used and are therefore 
relevant to a potential shift work application. Effects of light of these intensities 
may not show consistent results across all parameters considered, because 
different physiological responses can have differently shaped dose-responses 
to light. This may be why we do detect an effect on melatonin suppression, 
but no effect on sleepiness. This already suggests, and correlational analysis 
confirmed this, that under the light intensities used, there is no association 
between sleepiness and (physiological) melatonin concentrations at night. 
This is contrary to earlier results from Cajochen et al. (1996, 2000), but in 
line with the conclusion of Rüger et al. (2005). Interestingly, higher DPG was 
significantly associated with both increased sleepiness and lowered activation, 
in concordance with earlier experimental work (melatonin administration) 
carried out during the day (Kräuchi et al., 2006). 
Short-wavelength attenuated polychromatic white light negatively affected 
activation contrary to earlier reports (Kayumov et al., 2005; Rahman et al., 
2011). Also skin temperature, a physiological parameter linked to sleepiness 
and vigilance, was similar in the short-wavelength attenuated polychromatic 
white light condition and the dim light condition. These two results do 
suggest a possible decrement in overall performance, vigilance, and efficiency, 
although performance on an addition task was not negatively affected by short-
wavelength attenuated polychromatic white light. If exposure to full-spectrum 
light at night is indeed involved in the causation of the detrimental effects of 
shift work on health, short-wavelength attenuated polychromatic white light at 
night has the potential to improve health in shift work. Note that in our study 
we only included relatively young healthy males and that direct extrapolation 
towards a more variable shift work workforce with a wider range of ages and 
including females will require further study. Our results also indicate that 
short-wavelength attenuated polychromatic white light may not be applicable 
in all settings. Especially when safety of others or of the shift worker is at stake, 
implementation of a severe reduction of short-wavelength light might not be 
advisable.
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Supplementary Figures: Melatonin, distal-to-proximal skin temperature gradient (DPG), sleepiness 
and activation values obtained in the dim light condition were subtracted by the values obtained in 
either the short-wavelength attenuated polychromatic white light condition or the full-spectrum light 
condition, then averaged within subject, and subsequently z-transformed. Higher values indicate that 
higher melatonin, DPG, sleepiness and activation values were obtained in the dim light condition 
compared with the short-wavelength attenuated polychromatic white light or full-spectrum light 
condition. Lower values indicate that higher melatonin, DPG, sleepiness or activation values were 
obtained in either the short-wavelength attenuated polychromatic white light condition or the full-
spectrum light condition compared to the dim light condition.























































Difference in melatonin: dim minus short-wavelength attenuated 
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All cells in the body share the same genetic make-up. Therefore characteristics 
of individual cells in a certain tissue can resemble characteristics of cells in 
other tissues. In this study we show that the efficacy of melatonin suppression 
by light in vivo is negatively correlated to the excitability of the adenylyl cyclase 
(AC) – cyclic adenosine monophosphate (cAMP) – protein kinase A (PKA) 
pathway in cultured fibroblast cells. We reason that fibroblasts can be used as 
a model for brain-regulated melatonin suppression: melatonin suppression by 
light results from inhibition, via the SCN, of the PVN signal that eventually 
stimulates melatonin synthesis by the release of noradrenaline at the pineal 
cell. With higher light intensities lower noradrenergic stimulation reaches the 
pineal cells with lower melatonin synthesis as a consequence. If an individual 
has easily excitable melatonin producing cells, these cells will still produce 
melatonin upon a reduced noradrenergic signal. Hence, the suppression of 
melatonin by light will be limited. This observation can have consequences for 
the effects of light in patients suffering from seasonal affective disorder (SAD). 
SAD patients show higher levels of melatonin suppression by light than healthy 
controls. Those data have been interpreted to reveal high photosensitivity 
in SAD patients. Yet, depressive symptoms in SAD patients are reduced by 
increased light exposure (light therapy), suggesting sub-sensitivity to light. A 
novel hypothesis on cellular excitability solves this apparent contradiction. 
Serotonin production increases by light stimulation. An individual with high 
cellular excitability will produce more serotonin during daytime than a subject 
with low cellular excitability. High serotonin is predicted to combat depression. 
The same high cellular excitability will yield low melatonin suppression by light 
at night. Therefore the relationship between melatonin responses to light and 
depression may thus come about via a pleiotropic effect of cellular excitability.
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Introduction
Human behavioural timing (Roenneberg et al., 2007) and human circadian 
physiology (Burgess & Fogg, 2008) show large individual variation. Some 
of this variability is associated with prevalence of disease. For instance, sleep 
duration has been linked to mortality risk (Gallicchio & Kalesan, 2009; 
Kripke et al., 2002), and chronotype to obesity risk (Roenneberg et al., 2012) 
and the risk to develop type 2 diabetes (Merikanto et al., 2013). In mental 
illness, the large suppression by light of melatonin production (Nathan et al., 
1999; Thompson et al., 1990) and circadian phase shifting (Lewy et al., 2007) 
have been linked to depressive symptoms. Understanding the mechanistic 
basis for inter-individual differences in these processes is hampered by the 
impossibility of investigating living human brain tissue. Fibroblasts are one of 
the few human cell types available for sampling in subjects and their properties 
in culture have already been shown to be associated with timing of behaviour 
(Pagani et al., 2010). Although the ‘master clock’ controlling mammalian 
diurnal behaviour is located in the suprachiasmatic nucleus (SCN) in the 
brain (Ralph et al., 1990), its mechanism is cell-autonomous and conserved 
in most cells of the body (Ripperger & Brown, 2010). One of the best-studied 
rhythmic processes regulated by the human circadian clock, which is easily 
measurable in vivo, is melatonin concentration. This hormone is secreted 
at night, is rapidly suppressed by light, and is thought to signal time to the 
rest of the body (Arendt, 2006). Investigating individual differences in the 
melatonin suppression and/or synthesis pathway in human pineal gland tissue 
is impossible, but a large part of this signalling pathway is also functional in 
fibroblasts. To begin to unravel the mechanistic basis of individual differences 
in melatonin suppression by light, we investigated whether the excitability of a 
similar pathway in fibroblasts (in vitro) is correlated to melatonin suppression 
in saliva in the same subjects.
The SCN controls the circadian rhythm in melatonin synthesis. During 
daytime the SCN inhibits melatonin production by inhibiting the firing rate 
of the paraventricular nucleus (PVN). At night this inhibition is relieved. 
Signals from the PVN then stimulate the pineal gland via a multi-synaptic 
pathway. At the end of this pathway noradrenaline is excreted, which activates 
β1-adrenoceptors of the pineal cells (Simonneaux & Ribelayga, 2003). These 
receptors are coupled to a G-protein and binding activates adenylyl cyclase 
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(AC) (Sunahara et al., 1996). This enzyme catalyses the synthesis of the 
second messenger cyclic adenosine monophosphate (cAMP), which via the 
activation of protein kinase A (PKA) inhibits the lysis of the rate limiting 
enzyme serotonin-n-acetyltransferase (AANAT) thereby increasing melatonin 
synthesis (Ackermann & Stehle, 2006; Simonneaux & Ribelayga, 2003). Light 
at night inhibits this stimulatory signal coming from the PVN due to GABA-
ergic inhibition of the PVN by the SCN (Kalsbeek et al., 1999; Simonneaux 
& Ribelayga, 2003). This causes a reduction in AC activity and consequently 
reduced melatonin synthesis. 
We investigated the excitability of the AC – cAMP – PKA signalling pathway 
in fibroblasts, using forskolin. Forskolin binds, beyond the receptor, directly 
to the transmembrane enzyme AC. It has been shown to increase melatonin 
in a dose dependent manner in cultured pineal glands of the Syrian hamster 
(Santana et al., 1988). Direct stimulation of AC by forskolin causes an 
increase in intracellular cAMP (Sunahara et al., 1996; Zhang et al., 1997). 
cAMP activates PKA, which then phosphorylates and thereby activates 
cAMP response element binding (CREB) factor inside the nucleus. CREB 
is a member of the transcription activators family and is implicated in many 
pathways, including the circadian clock, light signalling, hormone synthesis, 
and depression (Blendy, 2006; Ginty et al., 1993; Lonze & Ginty, 2002). 
AC stimulation ultimately leads to the expression of different genes through 
binding of the phospho-CREB complex to gene promoter binding sites 
(Brindle & Montminy, 1992; Sands & Palmer, 2008). We investigated the 
pharmacodynamics of the AC – cAMP – PKA signalling pathway leading 
to the upstream phosphorylation of CREB in fibroblasts (in vitro) of the 
same subjects that were investigated for their degree of salivary melatonin 




16 subjects participated in the study. Data from 2 subjects could not be 
included due to a failure in culturing their fibroblasts. The remaining 14 healthy 
males (mean age [± SD] 21.9 ± 2.0 y) did not suffer from sleep disorders 
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(Pittsburgh Sleep Quality Index < 6; Buysse et al., 1989), somatic diseases, 
depressed mood (Beck Depression Inventory-II < 8; Beck et al., 1996, 2002), 
chronic diseases, colour blindness (Ishihara test; Clark, 1924), or visual 
impairment and did not use medication (general health questionnaire). They 
were recruited using advertisements. None of them had worked in night shifts 
or had travelled across more than 1 time zone respectively 3 and 1 month(s) 
preceding the study. They lived regular lives without smoking or drug, alcohol, 
or caffeine problems.  The subjects had an average chronotype (gender and age 
corrected mean midsleep on free days [±SD] 5:44 ± 44 min, rated through the 
Munich Chronotype Questionnaire [Roenneberg et al., 2003]). The Medical 
Ethics Committee of the University Medical Center Groningen approved the 
study and all subjects gave written informed consent.
experimental Design
The study consisted of 2 nights in the lab between June 19 and August 7, 
2010, the Netherlands. The two nights were separated by a minimum of 1 
and a maximum of 2 weeks. All subjects stayed in individual rooms. After 2 
hours of dim light (< 5 lux) exposure, subjects were randomly assigned to one 
of two conditions: dim light or full-spectrum light (Philips TL-D36W/830 
mounted on the ceiling, horizontal 627 ± 16 lux, vertical 164 ± 33 lux) from 
23:00 till 7:00 h. During the second night in the lab, subjects were exposed to 
the alternative light condition. Subjects stayed awake during the whole night 
and performed computer tests (the screen was covered with a colour filter to 
block blue light transmission, E-colour +, 105 Orange; Rosco Laboratories, 
London, UK) and completed questionnaires, which are not subject of this 
paper (Van de Werken et al., 2013). They received hourly snacks of 100 
Calories and 130 ml water. Each hour (from 21:30 till 6:30 h) saliva samples 
were collected for melatonin analysis, using cotton swabs (Salivettes®, Sarstedt 
B.V. Etten-Leur, The Netherlands). Melatonin concentration was quantified 
by radioimmunoassay (RK- DSM; Bühlmann Laboratories, Alere Health, 
Tilburg, The Netherlands). All samples from one individual were analysed 
within the same assay. Analytical sensitivity: 0.2 pg/ml. Intra- and inter-assay 
variations: 7.78% and 7.90%, respectively. Melatonin results are shown from 




Two 2 mm dermal punch biopsies were taken from each subject. These biopsies 
were shipped to the Institute of Pharmacology, Zurich, Switzerland, within 
48 h. As described previously (Brown et al., 2005), human primary fibroblasts 
were isolated from skin biopsies of these subjects by 4 - 7 h digestion of the 
tissues in 2 ml of DMEM containing 10% FBS, 1% Penicillin/Streptomycin, 
1% Gentamycin, 0.325 W.U./ml Liberase Blendzyme3. 
 
A novel cell - based reporter system was used for the measurement of the 
transcriptional activation of CREB in these cells. This system features a reporter 
construct coding the firefly luciferase downstream of a synthetic promoter 
which is joined to five tandem repeats of GAL4 binding elements. A separate 
transcriptional activator construct contains a coding sequence for activation 
domain of CREB fused with the DNA binding domain of yeast trans – 
activator GAL4.  In addition to the reporter and activator construct, a control 
normalizing lentiviral construct coding the secreted alkaline phosphatase 
(SEAP) was included. A lentiviral version of this reporter system was produced 
by the restriction cloning of the coding sequences of activator plasmids (pFA2 
- CREB) and reporter plasmids (pFR-Luc) into the pENTR4 gateway entry 
vector (Invitrogen) between attL1 and attL2 sites. Ultimately, Gateway® LR 
Clonase® II reaction was used to recombine and transfer inserts from entry 
vectors into a 3’LTR (long terminal repeats) of the promoter-less lentiviral 
destination vector containing either Hygromycin (pLDEST-CREB-Hygro) 
or Puromycin (pLDEST-FR-Luc-Puro) selection marker. All viruses were 
produced and concentrated as described in Cepko, 2001. 
Subsequently, semiconfluent plates of primary fibroblasts were initially 
transduced and selected for the lentiviral luciferase reporter construct 
carrying Puromycin resistance (pLDEST-FRLuc-Puro), and then additionally 
cotransfected with the activator (pLDEST-CREB-Hygro) and normalizing 
lentivirus vector (pLDEST CMV-SEAP Hygro).  Prior to bioluminescence 
measurement of the transcriptional activation, aliquots of the medium taken 
from the fully confluent samples were used to detect levels of secreted alkaline 
phosphatase by Phospha-Light™ Secreted Alkaline Phosphatase Reporter 
Gene Assay System (Cat. N. #T1015). Ultimately, DMEM medium high 
glucose, w/o phenol red, 10% KnockOut™ Serum Replacement, 1% Penicilin/
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Streptomycin, 1% Gentamycin, 0.1 mM Luciferin was used to measure basal 
levels of the light emission during 20 - 30 min. Subsequently, pathway specific 
drug stimulus was added to the tested samples (5 µM forskolin for CREB 
activation) and the signal was recorded over the 24 - 48 hours. 
A single experiment included samples measured in four replicates. Each sample 
was normalized by dividing the activator activity (maximal photon count 
value of CREB induction) by the control reporter activity (photon counts 
corresponding to SEAP values). Replicate samples were then averaged and the 
same calculation was done for all tests.
Statistical analysis
There are multiple ways of calculating melatonin suppression. We employed 
three different ways, which correct for inter-individual differences in general 
level of melatonin production (Burgess & Fogg, 2008), for example caused by 
differences in the size of the pineal gland (Gómez Brunet et al., 2002; Nölte et 
al., 2009). This was done because we wanted to relate individual responsiveness 
to light in vivo to sensitivity at the cellular level, rather than investigating 
individual differences in melatonin production.
Melatonin suppression was determined from 23:30 till 6:30 h by dividing the 
area under the curve (AUC) in full-spectrum light by the AUC in dim light 
(method 1). In some subjects the dim light melatonin onset (DLMO) occurred 
after lights were turned on. To correct for a small underestimation in melatonin 
suppression due to this, we calculated the AUC starting from DLMO in those 
subjects. The total time over which the AUC was calculated in all subjects was 
truncated to 5 hours and 26 min, determined by the one subject with the latest 
DLMO, which was at 1:04 h (method 2). Additionally we also investigated 
the maximal suppression in response to full-spectrum light disregarding phase. 
This approach is conservative in not assuming a similar phasing of melatonin 
production in the dim and full-spectrum condition. Starting from lights 
on or from DLMO (if a subject’s DLMO was after lights on), the minimal 
melatonin value measured in the full-spectrum light condition was divided by 
the maximum melatonin value in the dim condition (method 3). Spearman 
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Subjects showed large individual differences both in the suppressive effect of 
light on melatonin concentration and in CREB induction in their fibroblasts 
in response to forskolin (melatonin suppression ranges: method 1 = -5% to 
95%, method 2 = -6% to 97%, method 3 = 41% to 100%; CREB induction 
range: 102 to 503 P-CREB/SEAP, see Figure 1). We found that melatonin 
suppression and CREB induction were significantly negatively correlated 
(method 1: rs = -0.666, P = 0.009; method 2: rs = -0.600, P = 0.023; method 3: 
rs = -0.688, P = 0.007).
Discussion
A positive correlation between melatonin suppression and CREB induction 
might be expected because both depend on a similar signal-transduction 
pathway (AC – cAMP – PKA). Note however, that light at night does not 
actively decrease melatonin synthesis; it reduces the stimulatory noradrenergic 
signal that allows the pineal cell to produce melatonin, thereby reducing 
the inhibition of AANAT degradation, which finally leads to a decrease in 
melatonin synthesis (Simonneaux & Ribelayga, 2003). Therefore, based 
on excitability arguments, a positive correlation is expected between the 
percentages of remaining melatonin synthesis upon light exposure with CREB 
induction. This is similar to expecting a negative correlation between CREB 
induction and melatonin suppression, in accordance with the data. Our results 
therefore show that within an individual there is a similar degree of signal 
transduction strength in response to a stimulus both in their fibroblasts and in 
the neural circuitry regulating melatonin suppression. The data reveal that there 
Figure 1: CREB expression in fibroblasts predicts melatonin suppression in human subjects. Correlation 
between melatonin suppression (left y axis) or melatonin synthesis (right y axis) under full-spectrum 
light exposure with CREB induction in response to forskolin in fibroblasts from the same subjects. A) 
The area under the melatonin concentration curve under full-spectrum light divided by het area under 
the curve under dim light is plotted in relation to CREB induction (method 1, r
s
 = -0.666, P = 0.009). 
B) Same as in A, except that the areas under the curve were corrected for DLMO (method 2, r
s
 = 
-0.600, P = 0.023). C) The minimal melatonin concentration value under full-spectrum light divided by 
the maximal melatonin value under dim light is plotted in relation to CREB induction (method 3, r
s
 = 
-0.688, P = 0.007). Removal of the possible outlier on the right of the graphs still resulted in significant 
correlations in all 3 methods.
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is large variation in this response between individuals. The physiological basis 
of this variation likely involves mechanisms beyond the receptor, since forskolin 
directly activates AC. 
Based on this finding we hypothesize that individuals differ in their degree of 
‘cellular excitability’. Melatonin synthesis under light exposure, expressed as a 
percentage of maximal melatonin synthesis in dim light (thereby independent 
of pineal size), represents an indication of the degree of cellular excitability 
(Figure 2A). Individuals with relatively low cellular excitability show relatively 
higher degrees of light-induced melatonin suppression than individuals 
with relatively high cellular excitability (Figure 2B). This suggests a larger 
dependency upon the noradrenergic stimulus towards melatonin synthesis in 
subjects with low cellular excitability. Apparent differences in light sensitivity 
measured by melatonin suppression are predicted to be at least partly caused 
by differences in the intracellular response (excitability) to a stimulus, a trait 
inherent to the cell and to the individual (and similar at the central and 
peripheral levels). From this we have reasoned towards a general mechanism 
that explains apparent contradictions in the understanding of the relationship 
between melatonin suppression and depressive symptoms. Melatonin 
suppression is generally interpreted as a measure of non-visual light sensitivity 
(Nathan et al., 1999; Smith et al., 2004; Thompson et al., 1990) and is found 
to be higher in seasonal affective disorder and bipolar disorder compared to 
healthy controls, suggesting supersensitivity to light (Lewy et al., 1985; Nathan 
et al., 1999; Thompson et al., 1990). In contrast, patients benefit from light 
therapy treatment (Golden et al., 2005) and thus seem sub-sensitive to light.
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Figure 2: % Melatonin suppression determined by degree of cellular excitability. This figure illustrates 
the hypothetical relationship between extracellular stimulus strength (e.g. noradrenaline [NA]), which 
depends upon light intensity, and the resulting melatonin suppression and remaining synthesis. A 
different relationship is expected between SAD patients and healthy controls. A) Light at night causes 
the SCN to inhibit the PVN, resulting in reduced NA release in the pineal gland. A certain amount 
of NA release is expected when being exposed to moderate light intensities. Compared to maximal 
melatonin production under dim light (= 100%), a lower percentage of melatonin suppression by light 
is expected in high cellular excitability than in low cellular excitability. B) In moderate light intensities 
(indicated by the vertical dashed line) the difference in melatonin suppression between degrees of 
cellular excitability is most pronounced. Subjects with relatively high cellular excitability (indicated 
by the thick line) are less dependent upon stimulus strength to reach their maximum in melatonin 
synthesis. Whereas subjects with relatively low cellular excitability (indicated by the thin line) are more 
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Seasonal affective disorder (SAD) is characterized by recurrent episodes 
of major depression occurring with a seasonal pattern. In winter SAD the 
depressed state occurs during fall and winter with remission in spring and 
summer (Rosenthal et al., 1984). Both serotonin and noradrenaline are 
involved in the aetiology of depression. Therapy is commonly based on 
enhancement of serotonergic and/or noradrenergic neurotransmission via 
a variety of mechanisms that ultimately lead to an increase in monoamine 
concentration in the synaptic cleft (Kandel et al., 2000; Schloss & Henn, 2004). 
Particularly Serotonin Reuptake Inhibitors (SSRI’s) (Lam et al., 2006), but also 
noradrenaline reuptake inhibitors (Hilger et al., 2001), have been shown to be 
effective in the treatment of SAD. 
The effectiveness of light therapy has been established in many mood disorders 
(Golden et al., 2005) and is the preferred treatment in SAD; depressive 
symptoms improve already after one week of morning light exposure (Meesters 
et al., 1993) and the treatment has only minor adverse events (Lam et al., 
2006; Meesters & Letsch, 1998). Interestingly, the effectiveness of bright-light 
treatment in SAD depends on the availability of serotonin and noradrenaline 
as depletion of tryptophan or catecholamine abolished the effect of light 
therapy on mood (Neumeister et al., 1998). Higher amounts of light exposure 
have been linked to higher serotonin synthesis rates in humans (Lambert et al., 
2002) and similar effects have been shown experimentally in hamsters (Ferraro 
& Steger, 1990). Light has been shown to directly increase the discharge rate 
in a subpopulation of raphe neurons, part of the serotonergic system (Mosko 
& Jacobs, 1974). Electrical stimulation of serotonergic neurons caused an 
increase in the activation of tryptophan hydroxylase (the rate limiting enzyme 
in serotonin synthesis) and in the release of serotonin into the synaptic cleft via 
exocytosis (Boadle-Biber, 1993; Boadle-Biber et al., 1986). Besides that, there is 
a direct neural projection between the retina and the raphe nucleus, suggesting 
that light may directly increase serotonin production via this connection (Fite 
& Janusonis, 2001; Foote et al., 1978; Reuss & Fuchs, 2000; Shen & Semba, 
1994).
Because depression is linked to reduced brain serotonin levels and is relieved 
by light therapy, these findings suggest that SAD patients might be less 
photoreceptive and hence need more light to combat winter depression. 
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The opposite however has been shown to be the case: SAD patients show 
supersensitive responses to light in winter as measured by melatonin 
suppression (Nathan et al., 1999; Thompson et al., 1990). A history of low light 
intensity exposure has been shown to increase melatonin suppression (Hébert 
et al., 2002; Higuchi et al., 2007; Smith et al., 2004). However SAD patients 
and healthy controls have similar bright light exposure in winter (Graw et al., 
1999; Guillemette et al., 1998).
An explanation for the discrepancy in apparent light sensitivity differences 
could lie in the fact that light at night inhibits melatonin synthesis (Kalsbeek 
et al., 1999; Simonneaux & Ribelayga, 2003) whereas light during daytime 
stimulates serotonin synthesis and exocytosis, thereby increasing serotonergic 
neurotransmission. If a cell is not very responsive to the various stimuli it 
receives (low cellular excitability), an increase in strength of one specific 
stimulus can be determinative in reaching a certain threshold in synthesis 
capacity required for optimal functioning. Reduction of this stimulus (for 
example by light at night in the case of melatonin suppression) will lead to a 
relatively large drop in synthesis capacity (seen as relatively high melatonin 
suppression). Serotonergic neurotransmission could be insufficient in 
individuals with low cellular excitability, especially under reduced light 
exposure during fall and winter. Due to the stimulating effects of light, the 
required threshold levels are reached in summer. The increase in serotonin 
upon light treatment has been shown to be significantly higher (twice as 
high) in patients with major depression than in healthy controls, suggesting 
a larger dependency upon light in serotonergic neurotransmission (Rao et 
al., 1992). Although healthy individuals also show reduced serotonin levels 
in winter (Carlsson et al., 1980), they may not depend upon extra light to 
reach the threshold levels required to remain free of depressive symptoms, 
because their cells are more responsive to stimulation. Depressed patients are 
therefore predicted to show reduced levels of cellular excitability, at least during 
their depressed state. Indeed fibroblasts from patients diagnosed with major 
depression have a blunted β-adrenoceptor mediated PKA response leading to 
significantly reduced CREB induction compared to healthy controls (Manier 
et al., 2000). Many studies support the view that post-receptor disturbances 
in G protein-linked cAMP signalling play a major role in the pathophysiology 
of mood disorders (Chang et al., 2001; Perez et al., 2000). Different isoforms 
of proteins within this route may modulate signal transduction strength, as is 
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suggested for AC (Defer et al., 2000). Different levels of cellular excitability 
are also predicted to result in differences in absolute levels of melatonin 
production, however such differences are likely swamped by individual 
differences in pineal size (Nölte et al., 2009). The combination of lower light 
exposure in winter and low cellular excitability can explain why serotonergic 
neurotransmission is affected in SAD patients and why light therapy is 
beneficial. The combination of reduced noradrenergic stimulus input to the 
pineal gland caused by light exposure at night and low cellular excitability 
can explain large drops in melatonin synthesis (high melatonin suppression) 
in SAD. Light therapy may compensate for lowered cellular excitability, 
stimulating serotonergic neurotransmission, thereby combatting depression. We 
hypothesise therefore that the relationship between melatonin suppression and 
depressive disorders is caused by a pleiotropic effect of cellular excitability on 
depression and melatonin production rather than a causal relationship. 
Acknowledgements
We thank the subject volunteers for their participation and Wolter Stam, 
Vincent Hulst and Joop Luider for practical assistance. Financial support was 
obtained from the sixth European Framework project
EUCLOCK (018741).





eFFeCtS oF aRtiFiCiaL Dawn on SLeeP inteRtia,
Skin teMPeRatURe, anD the awakening 
CoRtiSoL ReSPonSe
Maan van de Werken1
Marina C. Giménez1
Bonnie de Vries1
Domien G. M. Beersma1
Eus J. W. van Someren2,3
Marijke C. M. Gordijn1
1Department of Chronobiology, Centre for Life Sciences,
University of Groningen, The Netherlands
2Department of Sleep & Cognition, Netherlands Institute for Neuroscience,
an institute of the Royal Netherlands Academy of Arts and Sciences,
Amsterdam, The Netherlands
3Departments of Clinical Neurophysiology, Neurology and Medical Psychology,
VU Medical Center, Amsterdam, The Netherlands




The effect of artificial dawn during the last 30 min of sleep on subsequent 
dissipation of sleep inertia was investigated, including possible involvement 
of cortisol and thermoregulatory processes. Sixteen healthy subjects who 
reported difficulty with waking up participated in random order in a control 
and an artificial dawn night. Sleep inertia severity was measured by subjective 
ratings of sleepiness and activation, and by performance on an addition and 
a reaction time task measured at 1, 15, 30, 45, 60, and 90 min after waking 
up at habitual wake up time at workdays. At all intervals, saliva samples were 
collected for cortisol analysis. Sleep electroencephalogram was recorded during 
the 30 min prior to waking up; core body temperature and skin temperatures 
were recorded continuously until 90 min after waking up. Subjective sleepiness 
was significantly decreased and subjective activation increased after waking up 
in the artificial dawn condition as compared with control in which lights were 
turned on at waking up. These effects can be explained by effects of artificial 
dawn on skin temperature and amount of wakefulness during the 30 min prior 
to the alarm. Artificial dawn accelerated the decline in skin temperature and in 
the distal-to-proximal skin temperature gradient after getting up. No significant 
effects of artificial dawn on performance, core body temperature, and cortisol 
were found. These results suggest that the physiology underlying the positive 
effects of artificial dawn on the dissipation of sleep inertia involves light sleep 
and an accelerated skin temperature decline after awakening.
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Introduction
During the period immediately after waking up people may suffer from 
confusion, disorientation, sleepiness and grogginess, and cognitive and physical 
performances may not be optimal. This transitory process is called sleep 
inertia (Dinges, 1990; Kleitman, 1963; Tassi & Muzet, 2000). The severity 
and duration of sleep inertia vary due to variations in sleep architecture, sleep 
stage upon awakening, and circadian phase (Scheer et al., 2008; Tassi & Muzet, 
2000). Under natural situations sleep inertia generates risks, in particular when 
performance immediately upon awakening must be high, for example when 
participating in traffic (Dinges & Kribbs, 1991; Seminara & Shavelson, 1969). 
It is of great interest for individuals and for society to understand the processes 
involved in waking up and to test methods to reduce sleep inertia. One of these 
methods is tested in this study, which experimentally addresses the effects of 
artificial dawn prior to waking up.
Sleep inertia is seen upon awakening from various sleep durations (Brooks & 
Lack, 2006; Jewett et al., 1999), and at all times of day and night (Naitoh et al., 
1993; Wilkinson & Stretton, 1971). Immediately after waking up, sleep inertia 
complaints are largest (Seminara & Shavelson, 1969). In the first hour after 
awakening, subjective alertness and cognitive performance rapidly improve, and 
sleep inertia slowly dissipates in an asymptotic manner ( Jewett et al., 1999). 
The severity of sleep inertia is mainly assessed by its intensity and duration 
(Tassi & Muzet, 2000). Reported durations of sleep inertia vary from several 
minutes (Wilkinson & Stretton, 1971) up to several hours (Naitoh, 1981). This 
large variation can be a consequence of the applied types of tests, for example, 
with high and low cognitive load, or the methods of analysis (Achermann et 
al., 1995; Ferrara & De Gennaro, 2000; Jewett et al., 1999; Muzet et al., 1995). 
Sleep inertia is influenced by preceding sleep and can be quite severe. After 
8 h of normal sleep, the effects of sleep inertia are reported to be modest and 
short-lived (Achermann et al., 1995; Jewett et al., 1999), nevertheless cognitive 
performance immediately after waking up is worse than after a night of total 
sleep deprivation (Wertz et al., 2006). 
Especially late chronotypes suffer from sleep inertia on a daily basis 
(Roenneberg et al., 2003); because of the demands of society they show a 
large discrepancy between obligatory and preferred timing of sleep (Horne 
& Östberg, 1976; Roenneberg et al., 2003; Zavada et al., 2005), resulting in 
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so-called social jetlag (Wittmann et al., 2006). The increased severity of sleep 
inertia of late chronotypes compared with early chronotypes may originate 
from three sources. First, their circadian phase in the morning is not optimal 
for high performance. Second, sleep duration during workdays is short because 
of late sleep onset and early wake up. Recovery sleep after partial or total sleep 
deprivation is known to increase the severity of sleep inertia (Balkin & Badia, 
1988), possibly due to increased amounts of slow-wave sleep (SWS; deep sleep) 
or to an increased chance of waking up from SWS (Dinges, 1990). Third, being 
sleepy in the morning motivates to get out of bed as late as possible, shifting the 
interval of severe sleep inertia to a period with high performance demands like 
commuting. 
In this study, we test if artificial dawn reduces the severity of sleep inertia in 
people who report having difficulty getting up in the morning on workdays. 
We also investigate possible physiological correlates of the induced effects. 
The process of waking up in the morning coincides with a wide range of 
physiological changes, among which changes in electroencephalogram (EEG) 
spectrum (Tassi et al., 2006), thermoregulatory changes (Kräuchi et al., 2004) 
and changes in cortisol level (Aschoff, 1978). These changes might be associated 
with the dissipation of sleep inertia. Changes in the distal-to-proximal skin 
temperature gradient (DPG) have been shown to correlate with sleepiness 
immediately after waking up (Kräuchi et al., 2004). Cortisol starts to increase 
during the second half of the night and is typically characterized by peak levels 
shortly after awakening (Edwards et al., 2001; Wüst et al., 2000). Waking 
up during the peak of the cortisol rhythm results in a short-lasting further 
elevation of the cortisol level (Edwards et al., 2001; Hucklebridge et al., 2005; 
Wüst et al., 2000); this elevation is called the awakening cortisol response. 
Elevated plasma cortisol levels during the second half of the night have been 
associated with an increase in stage 1 sleep, movements, and wakefulness, 
supporting an awakening effect of cortisol (Born et al., 1986; Fehm et al., 
1986). This was confirmed experimentally by direct administration of cortisol 
during sleep (Born et al., 1989). Whether the awakening cortisol response is 
related to sleep inertia complaints is not known.
Light plays an important role in alerting the body (Cajochen et al., 2000; Rüger 
et al., 2003), both during the day and during the night (Phipps-Nelson et al., 
2003; Rüger et al., 2006). Furthermore, bright light after waking up in the 
morning has been shown to increase cortisol levels in healthy humans while 
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light at other times of the day does not (Leproult et al., 2001; Rüger et al., 
2006; Scheer & Buijs, 1999). 
Few studies test the effects of a dawn light signal in the early morning on 
physiological and psychological parameters. Dawn simulation that started 
during sleep increased the awakening cortisol response (Thorn et al., 2004) 
and improved sleep quality (Leppämäki et al., 2003) in healthy individuals. 
A dawn signal has been shown to decrease depressive symptoms in seasonal 
affective disorders (SAD; Avery et al., 1993; 2001; Terman et al., 1989) and 
has been shown to be effective in decreasing sleep inertia in patients with SAD 
and subsyndromal SAD (Avery et al., 2002; Norden & Avery, 1993). Dawn-
dusk simulation light therapy has been shown to improve sleep quality and to 
advance sleep timing in demented elderly (Fontana Gasio et al., 2003).  
This lab study involved two conditions in which only the dawn period during 
the last 30 min of sleep was manipulated. A condition with artificial dawn 
during sleep and light at waking up was compared with a condition with light 
at waking up only. The purpose of this experiment was to investigate the effect 
of artificial dawn during sleep on sleep inertia and physiological processes in 
people who regularly have to wake up earlier than desired. Three aspects were 
investigated: sleep architecture during the stimulus; body (core and skin) 
temperature regulation; and cortisol production immediately after waking up, 
in relation to sleepiness, activation, stress, and performance measures. 
Materials and Methods 
Subjects
Subjects were recruited by advertisements in public places and at the University 
of Groningen. Sixteen healthy subjects (eight men and eight women, mean age 
[±SD] 22.8 ± 4.6 years) were selected, based on the following criteria: subjects 
had to be between 18- and 36-years old and live a regular life that consisted of 
at least four working days a week. On these days, they had to report that they 
need at least 60 min to fully wake up in the morning (rated on the Munich 
Chronotype Questionnaire [MCTQ]; Roenneberg et al., 2003). This selection 
resulted in relatively late chronotypes: mean midsleep on free days (MSF) 
(±SD) 5:53 ± 64 min (range from the same age categories, mean MSF 4:25 – 
5:23 h, Dutch population; Zavada et al., 2005), who also had a relatively large 
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‘social jetlag’ mean (±SD), 1.88 ± 0.82 h (Wittmann et al., 2006). To obtain a 
marker for circadian phase, MSF corrected for sleep deficit accumulated over 
the workweek (Roenneberg et al., 2007) was calculated: mean MSFsc (±SD) 
5:23 ± 64 min. Other subject characteristics (mean ± SD) were: timing of 
lights off on workdays 23:48 ± 53 min; timing of alarm on workdays 7:53 ± 54 
min; time needed to fully wake up on workdays 1.75 ± 0.87 h; phase angle 
between MSFsc and start of artificial dawn 1.99 ± 0.76 h (range 0.77–3.43 h). 
Subjects were healthy, did not suffer from (winter) depression (Beck Depression 
Inventory-II, Dutch version, BDI-II_NL ≤ 8; Beck et al., 1996, 2002) or sleep 
disorders, and did not use medication including sedatives, except for oral 
contraceptives (three women), NuvaRing® (Organon, Oss, The Netherlands) 
(one woman), hormone spiral (one woman) and copper spiral (one woman). 
Shift workers and persons who had experienced transmeridian flights within 
the last month were excluded from the study. All subjects were born and raised 
in the Netherlands so that they were fully able to understand the Dutch 
questionnaires. All subjects gave written informed consent and were paid for 
their participation. The experimental protocol was approved by the Medical 
Ethics Committee of the University Medical Center Groningen.
Subjects were asked to keep a sleep-wake schedule for workdays during 
the 7 days at home prior to participation, and to take no naps during the 
experimental days. In most cases, subjects would participate on the same day of 
the week in the control and artificial dawn condition (maximum difference 2 
days). Drinking coffee or alcohol on the days of participation was not allowed. 
All subjects reported to have kept to this regime. 
experimental Design
Subjects came to the human time isolation facility of the Department of 
Chronobiology at the University of Groningen on two occasions (control 
condition and experimental condition; Figure 1), consisting of two nights 
each. Subjects were free to go home during the day in between. Subjects stayed 
in individual living and bedrooms with no information about time of day. 
All rooms were completely dark, without windows. The living room was lit 
by ceiling lighting resulting in an intensity of 300 lux measured at eye level in 
the direction of the computer screen. During all four nights of the experiment 
subjects slept according to their habitual sleep time on workdays.
Condition order was randomized, and there was a minimum of 1 week between 
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conditions. The first night of each condition served as an adaptation night, 
which was not followed by a testing period in the morning, and subjects were 
allowed to leave after breakfast. The second night was either the control or 
experimental night, followed by a testing period of 90 min after which subjects 
were allowed to leave. Adaptation and control nights did not have a period of 
artificial dawn prior to wake up, instead, simultaneously with the audible alarm, 
the light was switched on with an intensity of 300 lux, measured at eye level in 
the direction of the Wake-up Light at 40 cm distance (the Wake-up Light is 
modified in such a way that no period of artificial dawn preceded the alarm; 
Philips DAP B.V., Drachten, The Netherlands). The experimental night was 
concluded with a 30-min period of artificial dawn, in which the light increased 
(up to the maximum of 300 lux) before the alarm and remained on after the 
audible alarm (normal Wake-up Light; Figure 5). Two Wake-up Lights were 
used, placed on either side of the bed to make sure that the subjects were 
exposed to the light. The Wake-up Light uses a 100-W light bulb (HalogenA 
Pro, Philips Lighting, Eindhoven, The Netherlands). Each night was ended by 
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Figure 1: Scheme of the experimental design. Subjects arrived 3 h before habitual bedtime. All tests 
and questionnaires were made twice during this period to get familiar to them. The first night (N1) 
served as an adaptation night. The second night (N2) was either the control night or the experimental 
night, which ended in a 30-min period of artificial dawn. The first test session started 1 min after 
waking up, the last test session started 90 min after waking up. (A) Relative time to habitual midsleep on 
workdays (h). (B) Accompanying example if habitual sleep time on workdays is from 23:00 to 07:00 h.
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the same moment, a researcher entered the room to make sure that the subjects 
got out of bed immediately. They subsequently walked to their individual living 
room and stayed seated behind the computer for the 90-min testing period. 
They were allowed to visit the toilet once preferably between 15 and 30 min 
after the audible alarm. All recordings were carried out between 16 January and 
15 March 2007.
Measurements
Sleep Inertia: Subjective Ratings and Performance
All questionnaires and performance tasks were practiced twice on each of the 
four evenings in the lab. Subjective ratings of sleepiness (Karolinska Sleepiness 
Scale [KSS]; Åkerstedt & Gillberg 1990) were obtained at 1, 15, 30, 45, 60, 
and 90 min after the alarm. Ratings on the KSS range from 1 to 9, with 1 
meaning very alert and 9 meaning very sleepy. Subjective ratings of activation 
and stress (two factors of the Thayer adjective checklist; Thayer 1967), with 
ratings ranging from 10 = minimal up to 40 = maximal, were obtained 1, 30, 
60, and 90 min after the alarm. At 1, 30, 60, and 90 min after the alarm two 
performance tasks were conducted. The first one was an addition task in which 
subjects were asked to make as many correct additions as possible within a 
3-min period. All additions consisted of two numbers of two digits.
The second task was a simple reaction time task in which during 2 min,
30 stimuli were presented with varying intervals. Subjects had to respond by 
pressing the spacebar as quickly as possible. For the calculation of the average 
reaction time, lapses (response time > 500 ms) and anticipatory responses 
(response < 150 ms) were excluded.
Body Temperature
Core body and skin temperatures were recorded throughout the night at a 
rate of one sample per minute. Recording ended immediately after the alarm 
following the adaptation nights, and after the last testing periods following 
the control and experimental night. Core body temperature was measured 
continuously by a rectal probe and recorded with the online wireless recording 
Puck Temperature Telemetry system (Ambulatory Monitoring, Ardsley, 
NY, USA). Skin temperature was measured using Ibuttons (DS1922L, 
Maxim Integrated Products, Sunnyvale, CA, USA; resolution 0.0625 °C; 
for validation, see Van Marken Lichtenbelt et al., 2006) that were placed on 
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11 locations: both hands (ventral part of left and right wrist) and both feet 
(inner part of left and right foot, just below the ankle bone); left and right 
infraclavicular region; inner part of left and right thigh; inner part of left and 
right calf; and one on the sternum. For the analysis distal skin temperature 
was calculated by averaging the skin temperature of both hands and feet, and 
proximal skin temperature was calculated as the average temperature of the 
left and right thigh, left and right infraclavicular region, and sternum using the 
following formula (see Mitchell & Wyndham, 1969):
The data from the calf were excluded in calculating proximal skin temperature 
because they appeared to represent intermediate values between those from 
distal and proximal locations. The DPG was calculated as the difference 
between distal minus proximal skin temperatures.
Only the last 30 min of sleep until 90 min after the alarm will be compared 
between conditions for core body and skin temperature. One male subject had 
to be excluded from the analysis of skin temperature because data of some skin 
temperature locations were missing. 
Cortisol
Saliva samples for cortisol analysis were taken at 1, 15, 30, 45, 60, and 90 min 
after the alarm, using Salivettes® with a cotton swab (Sarstedt B.V., Etten-Leur, 
The Netherlands). During the 90 min eating and drinking (other than water) 
were not allowed. A coated tube radioimmunoassay cortisol kit was used to 
determine cortisol levels (Spectria, Orion Diagnostica, Espoo, Finland). Each 
series from one individual was analysed within the same assay; sensitivity: 
0.19 nmol L-1 (lower limit); intra- and inter-assay variations: 3.9 and 6.7%, 
respectively.
Sleep EEG
Sleep EEGs were recorded during all four nights. EEG derivations consisted of 
C3-A2, Fz-A1, in addition to two electrooculogram (eye movements) and two 
proximal skin temperature =
average thigh + (
2




electromyogram (EMG; muscle tone) electrodes. The EEG recordings were 
low-pass filtered at 30 Hz (24 dB oct-1) and digitized at a sample rate of 128 
Hz. Sleep stages were visually scored on 30-s epochs according to the criteria 
defined by Rechtschaffen & Kales (1968). For the present purpose, only the last 
half hours of sleep in the control condition and the artificial dawn condition 
were analysed.
Statistical analysis
The differences over time of subjective ratings of sleepiness, activation, stress 
and performance on an addition and reaction time task were tested with a 
repeated-measures ANOVA, with two within factors (time and condition). 
The first measurement after waking up was tested separately to check whether 
already at this moment a difference could be observed between the control 
and artificial dawn condition. Similar statistics was used to test the pattern of 
cortisol concentration over time.
To determine the effects of light condition on core body, distal skin, proximal 
skin and DPG temperature profiles, mixed effect regression analysis (also 
known as hierarchical or multilevel analysis) were applied using MLwiN 
software (Centre for Multilevel Modelling, Institute of Education, London, 
UK). These analyses take into account the interdependency of the data points 
inherent to the hierarchical structure of the design, in our case the 1-min 
interval sequential temperature measurements  i that were nested within days j, 
once more nested within participants k (Twisk, 2003). Moreover, the software 
package allows for the definition of an autocorrelated residual error data 
structure, which cannot be neglected in frequently sampled temperature values. 
After observation of the temperature curves and based on our hypothesis, the 
following model equation was used to fit the data:
Temperatureijk = β0ijk + β1 × Dawnijk + β2 × tpostijk + β3 × Sqrt(tpost)ijk +
 β4 × Dawn × tpostijk + β5 × Wakefulnessijk + 
 β6 × Wakefulness × tpostijk
where β0 represents the model intercept, β1 the main effect of the artificial dawn 
condition (Dawn) as present from the start of dawn signal to the end of the 90-
min post alarm period, β2 and β3 together represent the non-linear time course 
of the decline in temperature after getting up (tpost indicates the time since 
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getting up), β4 the linearly increasing difference between the artificial dawn 
and control temperature time courses after getting up, β5 the main effect of the 
amount of wakefulness during the 30 min prior to the audible alarm, and β6 the 
effect of wakefulness prior to the alarm on the rate of decline of temperature 
after getting up. Parameters β1 describe the main (time-independent) effect of 
artificial dawn, and β4 its accelerating effect on the decline in temperatures after 
getting up. The autocorrelation of residual errors was included in the model 
as an exponentially decaying function of the time interval between successive 
temperature measurements. Maximum likelihood was used to estimate the 
regression coefficients, which were tested for significance with the z-test. 
To determine if cortisol concentration during the period of artificial dawn 
is already influenced, the difference in cortisol concentration at 1 min after 
waking up was analysed first, using a paired samples t-test. The effect of artificial 
dawn over time was analysed using repeated-measures ANOVA (both the 
whole 90 min and the first 30 min based on the results found by Thorn et al., 
2004). The highest peak during the 90 min after waking up was analysed using 
a paired samples t-test and the difference in the timing of the highest peak in 
cortisol concentration was analysed using a ‘sign’ test. For graphical purposes 
only (Figure 4), cortisol samples were normalized as follows: all samples per 
subject were divided by the average of all samples over both conditions of that 
subject and then multiplied by 100%. 
The differences between conditions for percentages of sleep stages, sleep 
efficiency, first arousal, accumulation of wakefulness, and final wake up 
time were tested with the Wilcoxon matched-pairs signed rank test, and the 
difference in sleep stage on final awakening with a chi-square test.
A mixed effect multiple regression analysis (MLwiN software) was used to 
determine whether sleepiness and activation scores could be predicted (other 
than by the time since alarm, dawn and their interaction) by the physiological 
parameters ‘momentary temperature’ (core, distal, proximal, DPG), 
‘momentary cortisol’ and ‘wake/sleep stage duration during the final 30 min 
prior to the alarm’ (movement time, W, S1-4, rapid eye movement [REM]). To 
determine if circadian phase could explain sleepiness and activation scores, the 
phase angle between MSFsc and start of artificial dawn was added to the model. 
To investigate whether artificial dawn had a differential effect on sleepiness 
and activation depending on circadian phase, the interaction between dawn 
and circadian phase was tested. By the use of the -2 × loglikelihood the most 
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parsimonious model was selected using backward selection. Ancillary analyses 
using forward selection led to identical results. The significance of regression 
coefficients was tested with the z-test. Values are described as average ± SEM. 
All tests are performed with α = 0.05, two-tailed.
Results 
Subjective Ratings and Performance
Sleepiness (KSS) was highest shortly after waking up and decreased significantly 
during the following 90 min (Figure 2A; F5,11 = 14.11, P < 0.001), whereas 
subjective ratings of activation (Thayer-activation) showed the opposite pattern 
(Figure 2B; F3,13 = 21.03, P < 0.001). Significantly lower levels of sleepiness 
(F1,15 = 4.58, P < 0.05) and higher levels of subjective activity (F1,15 = 7.58, P 
< 0.02) were found in the 90 min after artificial dawn compared with the same 
period in the control condition. At the first time point after waking up, neither 
sleepiness nor activation differed significantly between the artificial dawn and 
control condition (sleepiness: F1,15 = 0.32, NS; activation: F1,15 = 3.09, NS). 
There was no significant interaction between condition and time, neither for 
sleepiness (F5,11 = 1.44, NS) nor for activation (F3,13 = 0.79, NS), meaning that 
there was no significant deceleration/acceleration of sleepiness and activation 
after waking up between conditions. The subjective stress levels (Thayer-stress) 
were very low (data not shown) and there was no significant difference in 
pattern over time (F3,13 = 3.33, NS). No significant main effect (F1,15 = 3.07, 
NS) or interaction effect (F3,13 = 1.63, NS) over time was found between 
conditions. The first stress rating after waking up did not differ between the 
artificial dawn and control condition (F1,15 = 0.08, NS).
Performance was measured by addition and simple reaction time tasks. On 
the addition task, both the number of correct additions and the total number 
of additions increased over the 90-min wake time after the audible alarm. The 
number of correct additions at 1 min after waking up increased from 35.6 ± 2.3 
to 43.2 ± 2.0 at 90 min after waking up (F3,13 = 9.21, P < 0.01), and the total 
number of additions increased from 37.0 ± 2.3 to 44.3 ± 2.1 (F3,13 = 12.73, P < 
0.001) with no significant differences between conditions (correct additions: 
F1,15 = 0.11, NS; total additions: F1,15 = 0.16, NS) and no significant interaction 
between condition and time (correct additions: F3,13 = 1.55, NS; total 
additions: F3,13 = 1.09, NS). At the first time point after waking up, neither 
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Figure 2: Average (±SEM) subjective ratings in the control (open 
symbols) and artificial dawn conditions (closed symbols) during the 90 
min after the audible alarm for: (a) Sleepiness (KSS, 1 = low and 9 = high 
sleepiness); (b) Activation (Thayer adjective checklist, 10 = low and 40 = 
high activation) (n = 16).
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number of correct additions nor total number of additions differed significantly 
between the artificial dawn and control condition (correct additions: F3,13 = 
0.55, NS; total additions: F1,15 = 0.49, NS).
On the simple reaction time task, a significant reduction in reaction time over 
time was found (average reaction time 1 min after waking up: 270.5 ± 5.0 ms, 
decreasing to 258.4 ± 3.7 ms at 90 min after waking up, F3,13 = 8.08, P < 0.01), 
but no significant differences were found between conditions (F1,15 = 1.37, NS), 
nor was there a significant interaction effect between condition and time (F3,13 
= 0.66, NS). The first measurement after waking up did not differ between the 
artificial dawn and control condition (F1,15 = 0.00, NS).
Skin and Core Body temperatures
As shown in Figure 3, the artificial dawn condition did not significantly affect 
temperatures while still in bed, but did accelerate the decline in distal and 
proximal skin temperature, and their difference, after getting up. The mixed 
effect regression model fitted the time course of the temperature measures well, 
and confirmed that there were no significant main effects of artificial dawn on 
distal temperature (β1 estimate = -0.06 ± 0.15 ˚C, NS), proximal temperature 
(-0.15 ± 0.13 ˚C, NS), DPG (0.10 ± 0.14 ˚C, NS); or core body temperature 
(-0.11 ± 0.07 ˚C, NS). In contrast, artificial dawn significantly accelerated 
the decline in skin temperatures after getting up, most strongly so for distal 
temperature (β4 estimate = -0.36 ± 0.04 ˚C h-1, P < 0.0001), less prominent but 
still significant for proximal temperature (-0.07 ± 0.03 ˚C h-1, P < 0.03), and 
strong as well for DPG (-0.29 ± 0.03 ˚C h-1, P < 0.0001). The increase in core 
body temperature after getting up was not significantly accelerated by artificial 
dawn temperature (β4 estimate = 0.003 ± 0.007 ˚C h-1, P = 0.68).
awakening Cortisol Response
Cortisol concentration 1 min after the alarm did not differ significantly 
between the control and artificial dawn condition (control: 10.4 ± 1.3 nmol 
L-1; dawn: 12.1 ± 1.5 nmol L-1, t = -1.30, NS). The concentration changed 
significantly over the 90 min after waking up (F5,11 = 10.97, P = 0.001), with the 
highest concentration on average 34.7 ± 1.8 min after the alarm in the control 
condition and 30.9 ± 2.9 min after the alarm in the artificial dawn condition 
(sign test, NS; Figure 4). Artificial dawn did not affect the peak concentration 
(control: 24.3 ± 2.2 nmol L-1, dawn: 24.5 ± 1.9 nmol L-1, t = -0.13, NS). No 
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significant main effect of artificial dawn (F1,15 = 1.86, NS) nor a significant 
artificial dawn by time interaction effect (F5,11 = 1.99, NS) was observed over 
the 90 min in the amount of cortisol. The main effects of artificial dawn and 
the interaction effects with time during the first 30 min after waking up were 
tested separately. This was performed based on our hypothesis that the major 
changes in cortisol could be expected until the peak in the awakening cortisol 
response was reached after approximately 30 min (see also Thorn et al., 2004). 
No significant effects of artificial dawn on cortisol during the first 30 min were 
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Figure 3: Average (±SEM) patterns of distal and proximal skin temperatures, of distal-to-proximal 
skin temperature gradient (DPG), and of core body temperature starting 30 min prior to the audible 
alarm (at 0) until 90 min after the alarm in the control (circles, open symbols) and the artificial dawn 
(squares, closed symbols) conditions. The lines represent the best-fitted curve through the data 




No significant differences between both conditions were found in the 
percentages of each sleep stage during the last 30 min prior to the audible 
alarm (Table 1). A non-significant trend towards more wakefulness was seen 
in the artificial dawn condition compared with control (Z = -1.81, P = 0.07). 
Sleep efficiency (percentages of stages 2 + 3 + 4 + REM in the 30 min) was 
78.1 ± 4.7 and 69.8 ± 4.8% in the control and the artificial dawn conditions, 
respectively (Z = -1.57, NS).
From the EEG recordings, the onset time of the first arousal after the start 
of artificial dawn and the onset time of the last arousal not followed by sleep 
was scored. An arousal was defined as a switch to either wakefulness, stage 1 
or movement time. The timing of the last arousal without subsequent sleep, 
by definition, is wake up time. The first arousal within the 30 min prior to 
the audible alarm occurred on average 6.5 ± 1.8 min and 7.7 ± 1.9 min after 
the start of the 30-min period in the control and artificial dawn conditions, 
respectively (Z = -0.41, NS). In the artificial dawn condition, this corresponded 
with a light intensity of 1.8 lux measured at the pillow, facing the Wake-up Light. 
Between 5 and 10 min after the start of the 30-min period, the accumulation of 
wakefulness started to differ between conditions. In this period, light intensity 
in the experimental condition increased from 0.4 to 4.5 lux. Only between 
10.5 and 14.5 min after the start of the 30-min period the cumulative amount 
of arousals in the artificial dawn condition reached significance compared with 
Figure 4: The average 
(±SEM) course of cortisol 
during the control (open 
symbols) and artificial dawn 
(closed symbols) conditions 
at 1, 15, 30, 45, 60, and 90 
min after the alarm. Cortisol 
levels were normalised 
with respect to the average 
cortisol level (of both 
conditions) of each subject 
(n = 16). 
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the control condition (two-tailed P-values between 0.04 and 0.09). The light 
intensity increased during this period from 5.4 to 17.8 lux. Most subjects fell 
asleep again after short periods of wakefulness between 10.5 and 14.5 min 
after the start of dawn. The final wake up time differed significantly between 
conditions (Z = -2.59, P = 0.01), but the difference was small: 2.2 ± 0.9 min 
before the alarm in the control; and 4.7 ± 1.1 min before the alarm in the 
artificial dawn condition (Figure 5). 
Sleep stage on final awakening did not differ between conditions (control: eight 
subjects REM sleep and eight subjects Stage 2; artificial dawn: seven subjects 
REM sleep and nine subjects Stage 2 (chi-square, NS).
Table 1: Average percentages of each sleep stage (±SEM) during the last 30 min prior to the audible 
alarm in the control and artificial dawn conditions (n = 16). 
Sleep stage (%) Control Artificial dawn Z P
Stage 1  10.3 ± 2.2   12.3 ± 3.1 -0.57 NS
Stage 2  36.5 ± 8.4  40.5 ± 10.1 -0.17 NS
Stage 3    0.1 ± 0.1   0.1 ± 0.0   0.00 NS
Stage 4    1.4 ± 1.4   0.0 ± 0.0  -1.00 NS
Wakefulness  10.3 ± 3.9 16.7 ± 4.2  -1.81 0.07
REM sleep  40.2 ± 9.0 29.2 ± 7.3  -0.83 NS
Movement time    1.3 ± 0.4    1.3 ± 0.3   0.00 NS
NS, not significant; REM, rapid eye movement.
Time since start artificial dawn (minutes)
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Figure 5: Rise in light 
intensity (lux) of the Wake-
up Light (solid line) starting 
30 min prior to the audible 
alarm (at 30). In the control 
condition (dashed line) 
the light was switched on 
at the audible alarm. Mean 
(±SEM) first arousal in the 
control (white circle) and 
the artificial dawn (white 
square), and mean (±SEM) 
wake up time in the control 
(black circle) and the 
artificial dawn (black square).
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Parameters explaining Subjective Ratings
To test what physiological parameters contributed to the significant differences 
in sleepiness and activation between the artificial dawn condition and the 
control condition, a mixed effect multiple regression analysis was performed 
(see Section ‘Materials and methods’ for procedure).
Sleepiness could best be explained by the following model:  
Sleepinessijk =  β0ijk + β1 × Distal-temperatureijk + β2 × Wakefulnessijk +
 β3 × Sqrt(tpost)ijk
Sleepiness was positively related to momentary distal skin temperature (β1 
estimate = 0.31 ± 0.10 unit of sleepiness ˚C-1, P < 0.01); negatively to the 
amount of wakefulness in the half hour prior to the alarm (β2 estimate = -0.16 
± 0.05 unit of sleepiness min-1, P < 0.01); and to sqrt(tpost) (-0.14 ± 0.05 unit 
of sleepiness min-1, P < 0.01). 
Activation could best be explained by the following model equation:  
Activationijk =  β0ijk + β1 × Distal-temperatureijk + β2 × Wakefulnessijk +
 β3 × Cortisolijk
Activation was negatively related to the momentary distal skin temperature (β1 
estimate = -1.77 ± 0.13 unit of activation ˚C-1, P < 0.01) and to the momentary 
cortisol concentration (-0.07 ± 0.04 unit of activation per nmol L-1, P < 0.05), 
and positively related to amount of wakefulness prior to waking up (0.50 ± 0.15 
unit of activation min-1, P < 0.01). 
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Discussion
In this study, we confirmed that sleep inertia (subjective ratings on sleepiness 
and activation, and performance) is most severe immediately after waking up 
and decreases during the following 90 min (Achermann et al., 1995; Jewett 
et al., 1999; Wertz et al., 2006). When exposed to 30 min of artificial dawn 
prior to the alarm, subjects felt less sleepy and more active during the 90 min 
after waking up compared with the 90 min in the control condition. These 
differences between conditions in sleepiness and activation scores were not 
apparent in the first minute after waking up. This may be due to either statistical 
power or indicate a fundamental property of the waking up process itself. 
Obviously the repeatedly lower sleepiness and higher activation values during 
the 90-min waking period after artificial dawn compared with the same period 
in the control condition resulted in a significant main effect, but the variance 
in the data could be too high and the number of subjects too low to be able to 
find a significant difference at only one time point (immediately after waking 
up). On the contrary, ‘the waking up process’ may take some time and may only 
become apparent after waking up. 
For the purpose of the study, subjects were selected who substantially suffer 
from sleep inertia. They reported to require more than 1 h before feeling fully 
awake on workdays (Roenneberg et al., 2003). Chronotype evaluations (Zavada 
et al., 2005) revealed that late chronotypes are overrepresented in the sample 
of selected subjects, and that their sleep on workdays is much earlier than on 
free days. MSF as obtained by the MCTQ has been shown to correlate to 
Morningness-Eveningness Questionnaire (MEQ) scores (Zavada et al., 2005), 
and both midsleep time and MEQ score have been shown to correlate to dim-
light melatonin onset (Martin & Eastman, 2002) and to other physiological 
circadian phase markers like body temperature and cortisol (Bailey & 
Heitkemper, 2001). Subjects within the present study differed in circadian 
phase as determined by their MSF corrected for sleep deficits accumulated over 
the workweek (MSFsc; Roenneberg et al., 2007). The start of artificial dawn 
and waking up time was in accordance to habitual wake up time on workdays. 
Because of these reasons, there was some interindividual difference in circadian 
timing of artificial dawn exposure and waking up. The phase angle between 
MSFsc and start of artificial dawn and subsequent waking up could, however, 
not explain sleep inertia severity; neither did it explain the effect of artificial 
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dawn. This is interesting because circadian phase is a major factor for the non-
visual effects of light exposure. It suggests that the artificial dawn in this study 
does not necessarily interact with the underlying circadian system but rather has 
an acute effect upon physiological processes around the moment of waking up 
irrespective of its timing within the present (narrow) range of circadian phases. 
In this study, it is shown that changes in skin blood flow and associated changes 
in skin temperature parallel the sleep inertia process; similar to how these 
thermoregulatory processes are correlated to the evening increase of sleepiness 
and the initiation of sleep after lights off in the evening. Sleep is typically 
initiated when heat loss is maximal and usually occurs during the circadian 
peak of skin temperature (Kräuchi, 2007; Van Someren, 2004) that is the major 
cause of the nocturnal decline in core body temperature rhythm (Campbell 
& Broughton, 1994; Kräuchi, 2007; Van Someren et al., 2002; Zulley et al., 
1981). In the morning, the opposite occurs when heat production is dominant 
over heat loss, resulting in an increase in core body temperature (Kräuchi, 
2007). In this study, subjects changed from supine to upright position after 
waking up. This has caused strong masking effects in body temperature on 
top of the waking up process during both the control and artificial dawn 
conditions. Nevertheless, artificial dawn prior to waking up did result in an 
accelerated decline in distal and proximal skin temperatures after getting up, 
which was also reflected in an accelerated decline in the DPG. This suggests 
that vasoconstriction of skin blood vessels develops faster after being exposed 
to artificial dawn prior to waking up compared with the control condition. This 
could be explained by direct activation of the sympathetic nervous system by 
light (Saito et al., 1996; Scheer et al., 1999). 
Fluctuations in distal skin temperature are always larger than fluctuations in 
proximal skin temperature (Kräuchi, 2007). Therefore, it is not surprising 
that in this study the absolute effect of artificial dawn is larger in distal skin 
than proximal skin regions. Another explanation could be that artificial dawn 
interacts with the peripheral vasoconstriction caused by the change in body 
position and that this effect is stronger in distal skin regions.
During the 30 min of artificial dawn, there is little difference in visually scored 
sleep stages compared with the last 30 min of sleep in the control condition. 
The average timing of the first arousal (either wakefulness, stage 1 or movement 
time) did not differ between the artificial dawn and control condition. 
Therefore, the relatively low light intensity in the artificial dawn condition 
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during the first 10 min, in which these arousals occurred, did not wake up the 
subjects. However, during the following 5 min the accumulation of arousals 
was steeper in the artificial dawn condition than in the control condition. 
This period also coincides with a substantial increase in light intensity (from 
5.4 to 17.8 lux). Short arousals (periods of artefacts over EMG + EEG) occur 
regularly during the whole sleep period (Dijk et al., 1987; Gordijn et al., 1999), 
and most of them are not noticed by the person at all. Only some appear to be 
associated with conscious awareness of being awake. It is not known whether 
subjects were consciously aware of the light during an arousal and whether this 
has contributed to the observed changes after waking up. By asking the subjects 
afterwards, they reported to have noticed the difference between the artificial 
dawn and control conditions. It is also unknown whether subjects opened their 
eyes during an arousal. Only about 5% of light intensity comes through the 
eyelids (Ando & Kripke, 1996), and if subjects opened their eyes they were thus 
exposed to a much higher light intensity. 
Abrupt awakenings are reported to worsen sleep inertia complaints (Dinges, 
1990; Dinges et al., 1981). A gradual way of waking up, induced by artificial 
dawn, could thus reduce sleep inertia complaints.
Indeed in our regression analysis the amount of wakefulness during the 30 min 
prior to the alarm contributed both to the decrease in sleepiness and to the 
increase in activation after waking up. In addition to the amount of wakefulness 
prior to the alarm, the decrease in distal skin temperature after waking up 
contributed strongly to the model. Our data confirm the close functional 
relationship between the dissipation of sleepiness and skin temperature, as was 
previously reported in relation to DPG (Kräuchi et al., 2004). It is interesting 
that in our study distal skin temperature rather than DPG or proximal skin 
temperature added significantly to the model explaining sleepiness. Little 
is known about the association of the regulation of skin blood flow and the 
regulation of alertness upon waking up from sleep. Typically, a 10-min nap does 
not induce the adverse effects of sleep inertia upon awakening, and this may 
be because of insufficient time for thermoregulatory changes to occur (Brooks 
& Lack, 2006). Further experiments are required to determine whether skin 
temperature changes after waking up and the dissipation of sleep inertia are 
causally related, as has been shown to be feasible using mild skin temperature 
manipulation while obtaining objective vigilance measures during daytime 
(Fronczek et al., 2008; Raymann & Van Someren, 2007). This study is the first 
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to show that manipulation of sleep inertia by artificial dawn coincides with 
effects on skin temperature.
Interestingly, but also unexpectedly, the effect of the awakening cortisol 
response as included in the model on activation appeared to be negative. This 
negative relationship suggests that an increased awakening cortisol response 
has a detrimental effect on the dissipation of sleep inertia. The exact function 
of the awakening cortisol response is as yet unknown. Although cortisol does 
show consistent responses to stress (Kemeny, 2003), the morning increase 
in cortisol was not associated to any detectable psychological stress in our 
study. Previously, light after waking up has been shown to increase cortisol 
production (Scheer & Buijs, 1999), and one study showed a significantly 
higher awakening cortisol response with the use of a dawn waking up system 
(Thorn et al., 2004). In this study, we did not find an effect of the dawn signal 
on cortisol. The discrepancy between our study and the study of Thorn et al. 
(2004) can be explained by differences between the control conditions used in 
both experiments. In the study of Thorn et al. (2004) artificial dawn was tested 
against a normal alarm clock (with no light). In our study light was turned on 
in the control condition, together with the audible alarm at waking up. This was 
performed to test whether dawn itself, and not the light exposure after waking 
up, induced a reduction of sleep inertia and an increase in cortisol. It is possible 
that the light exposure immediately after the alarm in both conditions may have 
increased cortisol to such an extent that a possible additional effect of artificial 
dawn on cortisol could not be detected. 
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Conclusion
People who require a large amount of time after awakening before feeling fully 
alert can reduce their symptoms of sleep inertia and the time until feeling fully 
awake by exposing themselves to an artificial dawn signal. Skin temperatures 
showed an accelerated decline after awakening in the artificial dawn condition. 
A multiple regression analysis revealed that the physiological background 
explaining the positive effects of artificial dawn on the dissipation of sleep 
inertia involves light sleep and an accelerated distal skin temperature decline 
after awakening.
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Human cortisol levels follow a clear circadian rhythm (Czeisler et al., 1999; 
Linkowski et al., 1993). We investigated the contribution of alternation of sleep 
and wakefulness and the circadian clock, using forced desynchrony. Cortisol 
levels were best described by a multiplication of a circadian and a wake-time 
component. The human cortisol response is modulated by circadian phase. 
Exposure to stress at an unnatural phase, as in shift work (Boivin et al., 2007), 
is predicted to result in abnormal cortisol levels. Health of shift workers may 





Biological clocks regulate physiology and behavior. When external timing and 
internal timing are in sync, circadian regulation of our physiology remains 
largely unnoticed. Yet, when we fly across time zones or are up at night, this 
circadian regulation becomes apparent quickly and impacts negatively on 
well-being, performance and potentially health (Gillberg et al., 1994; Vyas 
et al., 2012; Waterhouse et al., 2007). Experimentally we can investigate 
such circadian regulation without the confounding effects of actual activity 
by gradually shifting the activity cycle across the internal period; a forced 
desynchrony protocol (Czeisler et al., 1999; Dijk & Czeisler, 1995; Hiddinga 
et al., 1997; Koorengevel et al., 2002). Here we apply forced desynchrony in 
nine subjects to investigate circadian cortisol regulation. Cortisol is a central 
hormone in our body regulating a wide array of bodily functions and responses 
to stressors. Moreover long-term elevation of cortisol levels has been linked to 
major diseases, e.g. obesity (Rosmond et al., 1998) and cardiovascular disease 
(Girod & Brotman, 2004; Whitworth et al., 2005). We discuss the relevance of 
circadian cortisol regulation for shift workers and test two specific theoretical 




Nine healthy subjects (5 males, 4 females; mean age [±SD] 22.7 ± 2.1 yr) did 
not have sleep disorders (Pittsburgh Sleep Quality Index < 6; Buysse et al., 
1989), somatic diseases, depressed mood (Beck Depression Inventory-II < 8; 
Beck et al., 1996), chronic diseases, colour blindness (Ishihara test; Clark, 
1924), or visual impairment (assessed by general health questionnaire). Subjects 
did not use medication on a regular basis during 3 months preceding the 
study (assessed by general health questionnaire). All women used hormonal 
contraception. Subjects did not work in night shifts or travelled across more 
than one time zone respectively 3 months and 2 weeks preceding the study. 
Subjects had an average chronotype for their age and gender (mean midsleep on 
free days [±SD] 4:56 h ± 40 min with a mean sleep onset [±SD] at 0:30 h 
± 46 min and a mean sleep offset [±SD] at 9:21 h ± 44 min, rated on the 
Munich Chronotype Questionnaire (Roenneberg et al., 2003). Subjects 
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reported that their lives contained at least five days a week with regular daytime 
activity and sleep exclusively at night. Subjects did not smoke or use drugs and 
did not report excessive intake of alcohol or caffeine. The study protocol was 
approved by the Medical Ethics Committee of the University Medical Center 
Groningen, the Netherlands, and conformed to international ethical standards 
(Portaluppi et al., 2008). All subjects gave written informed consent. They were 
financially compensated for their participation.
experimental Procedures
The study was carried out from March 28 till May 17, 2009. Subjects remained 
in a time isolation facility in individual rooms for one week. No information 
about time of day (no clocks or sunlight) was present. During the 4 days 
directly prior to the study, subjects were instructed to follow a regular sleep-
wake cycle at home (bedtime: ~00:00 h, wake-up time: ~08:00 h). The actual 
interval with forced desynchrony was preceded by an extra night in the lab 
to get familiar with the setup and tests and questionnaires (data not shown). 
Additionally, from 19:00 till 01:00 h hourly (in dim light < 10 lux), and 
from 1:00 till 9:00 h (in darkness, subjects went to bed from 00:00 – 9:00 h) 
every two hours saliva samples were collected for melatonin analysis, to 
determine circadian phase. After this first night subjects were free to go home 
but returned to the lab the same evening. The tests and questionnaires were 
again practiced by the subjects after which they had a normal 8.5 h night of 
sleep (from 00:00 – 08:30 h). The forced desynchrony protocol started upon 
waking up. Subjects were subjected to a sleep-wake cycle of 20 h; 13.5 h in 
dim-light (<10 lux) and 6.5 h in darkness. During the dark intervals subjects 
were instructed to try to sleep. During the dim-light intervals subjects needed 
to stay awake and were monitored by the experimenters accordingly. Each day 
had the same temporal structure. Because of this strict structuring we only 
analysed the cortisol data starting after the first night of sleep within the forced 
desynchrony protocol. The dim-light interval started by switching on the lights 
(< 10 lux) simultaneously with the alarm. Subjects had to get up immediately. 
They completed questionnaires and performed several tests (e.g. reaction time 
and addition tests, data not shown here). They collected saliva samples for 
cortisol and melatonin analysis at 1, 15, 30, 45, 60 and 90 min after the alarm. 
For the remainder of the subjective day, subjective ratings of sleepiness and 
activity, ratings on a food preference questionnaire and performance tasks were 
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collected every two hours (data not shown). Saliva samples for melatonin and 
cortisol analysis were collected and tympanum (eardrum) temperature was 
measured every hour (the latter data is not shown). Subjects had breakfast, 
lunch and dinner and took a shower according to a strict time schedule, which 
was respectively 1:45, 5:35, 9:35 and 3:35 h after waking up. The last subjective 
day of the experiment lasted 15.5 h (till 00:00 h). Saliva collections from 
23:00 till 1:00 h hourly, and from 1:00 – 9:00 h every two hours were only used 
for melatonin but not cortisol analysis. The experiment ended after subjects had 
a normal night of sleep from 00:00 – 9:00 h.
Measurements
Saliva samples were collected for melatonin and cortisol analysis using two 
separate salivettes prior to every questionnaire/test session: 1, 15, 30, 45, 60 
and 90 min after waking up using cotton swabs (Salivettes®, Sarstedt B.V. Etten-
Leur, the Netherlands). From here on saliva samples were collected hourly for 
the remainder of the subjective day. Eating and drinking was not allowed during 
the 90 min after waking up and 30 min prior to sampling during the remainder 
of the day. Subjects were to remain seated behind their desk at least 10 min 
prior to every sample taken.
After saliva was collected it was immediately stored at -20°C. Melatonin and 
cortisol concentrations were assessed by radioimmunoassay (Melatonin: RK-
DSM; Bühlmann Laboratories, Alere Health, Tilburg, the Netherlands and 
Cortisol: Spectria, Orion Diagnostica, Mediphos, Renkum, the Netherlands). 
Each sample was analysed once and all samples from each individual were 
analysed together within the same assay. Melatonin: analytical sensitivity: 0.2 
pg/ml; intra- and inter-assay variations: 7.8% (mean 14.5 pg/ml) and 4.4% 
(mean 15.6 pg/ml), respectively. Cortisol: analytical sensitivity: 0.44 nmol L-1 
(lower limit); intra- and inter-assay variations: 5.1% (mean 23.7 nmol L-1) and 
9.2% (mean 23.7 nmol L-1), respectively. All individual samples fell beyond the 
lower limit of analysis negating the problem of non-linearity of metrics used 
in forced desynchrony analysis (Achermann, 1999; Jewett & Kronauer, 1999). 
Both salivary melatonin and salivary cortisol levels have been demonstrated 
to correlate strongly with circulating blood levels, e.g. (Putignano et al., 2001; 




The choices for a wake-time related component and a circadian component 
were iteratively optimised per subject as follows. First the overall average 
cortisol concentration across the 108 data points was calculated. As a first step, 
it was assumed that, during wakefulness, the masking-component was constant 
over time, and equal to the calculated average. The masking-component was 
estimated in this way on a per-minute basis. Similarly, the raw cortisol data 
across the 120 h of the experiment were linearly interpolated during the wake-
intervals. The intervals of sleep were considered missing data. The circadian 
component was subsequently estimated by division (or subtraction, depending 
on the model) of the raw data by the thus defined wake-component and 
plotting the result at the appropriate circadian time, which was defined on the 
basis of the estimated tau (circadian period) from the individual’s melatonin 
data. This provided several results per circadian minute. Those results were 
averaged to yield an estimate of the circadian profile.
The per-minute interpolation of the data is necessary because the data were 
obtained at non-equidistant intervals, and because the period of the melatonin 
rhythms was not exactly equal to 24 h. The higher resolution of the analysis as 
compared to the resolution of the original data bears the risk of introducing 
oscillations in the results in a frequency range that is not included in the 
measurements. To avoid such artefacts, Fourier analysis was applied to the 
resulting circadian component. The 5 lowest frequency components (between 
about 1/24 h up to about 1/6 h) were used to reconstruct the circadian 
component. Higher frequencies were left out. The thus-defined circadian values 
were combined with the original masking-component (either by multiplication 
or by addition) and the results were compared with the original data by 
summing the squares of the differences. The sum of squares was minimized to 
improve the choice of the masking-component. This was done through stepwise 
increments or decrements per data point of the wake-component, first with 
large steps, later with smaller steps. The circadian component was calculated as 
explained above, and the resulting sum of squares was compared to the previous 
sum of squares. If the sum of squares decreased, the increment or decrement 
of the data-point was accepted as an improvement of the estimated wake-
component, and the procedure was repeated, until no further improvements 
were obtained. The resulting curves of each individual and the average 




Nine healthy subjects (5 males, 4 females) were subjected to a forced 
desynchrony protocol, by imposing six successive sleep-wake cycles with a 
period of 20 h; 13.5 h waking in dim-light (< 10 lux) and 6.5 h sleeping in 
darkness. This resulted in free running rhythms in melatonin in all subjects, 
with a period of 1452 min ± 4.5 (mean ± SD, Table 1, Figure 1, Figure S1). 
The similarity of successive ~24 h melatonin cycles demonstrates that the 
imposed 20 h sleep-wake cycle has little effect on melatonin production. This 
is consistent with earlier studies which concluded that melatonin is a robust 
output signal of the circadian clock relatively insensitive to masking effects 
(Wyatt et al., 1999). Cortisol concentrations, in contrast, showed pronounced 
changes over time suggestive of interference between a circadian rhythm with 
a period similar to the melatonin rhythm and masking effects induced by the 
13.5 h wake period (Figure 2). This interference between circadian phase and 
masking was especially apparent shortly after awakening (Figures 3 and 4). 
The forced desynchrony protocol included 6 imposed sleep-wake cycles of 
20 h, which equals 5 days of 24 h. Since the period of the melatonin rhythms 
turned out to be close to 24 h, the sleep-wake cycle stepped through the entire 
circadian cycle with -4 h intervals, providing a full set of phase combinations 
of the two rhythms. This allows for the mathematical separation of the 
masking and circadian components of cortisol production, which provides 
information about the underlying regulatory mechanisms responsible for 
cortisol production. Here we investigate two models for the interaction of the 
clock and masking: an additive and a multiplicative model. The additive model 
represents a physiological circadian system that yields specific levels of cortisol 
production by the mere addition of a circadian (~24 h) pattern in cortisol 
production and masking effects, such as induced by for example waking up 
triggering the awakening cortisol response (Clow et al., 2004). The masking 
effect and circadian effect are modelled in the additive model as resulting from 
independent pathways. The multiplicative model in contrast represents a system 
that responds to masking on the basis of a sensitivity that is controlled by 
circadian phase. In this model, if awakening occurs in the early morning, when 
circadian sensitivity is high, the cortisol response is proportionally higher than 
when awakening occurs in the evening, when circadian sensitivity is low. 
The two components were estimated by an iterative procedure as explained in 
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the section Analysis Details. By examining how well the extracted masking and 
circadian components combine under the additive and multiplicative models to 
fit the raw data, we can test both models against each other. Model comparisons 
were performed on the basis of AIC differences (Akaike Information Criterion, 
AIC increases compared to the best model can be interpreted as follows, models 
differing ≤ 2 the alternative model still has considerable support, models which 
difference are ≥ 4 ≤ 7 the alternative model has considerably less support, and 
with AIC differences of over 10 the alternative model has essentially no support 
[Burnham & Anderson,  2004]). Table 1 provides the ΔAIC values of the two 
Figure 1: Mean (±SEM) melatonin concentrations of all 9 subjects are indicated by the white dots. 
See Figure S1 for the individual melatonin curves. Average tau (1452 min) of all 9 subjects is plotted 
by the black line. Grey areas indicate periods of darkness during which the subjects were instructed to 
sleep. White areas indicate periods of wakefulness (< 10 lux). First day: hourly saliva collection from 
19:00 – 1:00 h and every two hours from 1:00 – 9:00 h. Subjects were instructed to sleep from 00:00 – 
9:00 h. Upon waking up subjects were free to go home (indicated by the asterisk) but returned to the 
lab the same evening and 3 saliva samples were collected at 22:00 h, 23:00 h and 00:00 h. Subjects 
had a normal night of sleep from 0:00 – 8:30 h. The forced desynchrony protocol started upon waking 
up. The last subjective day was extended by an extra 2 hours (additional saliva collection at 23:00 h). 
Subjects were instructed to go to bed at 00:00 h, but saliva collection was continued at 1:00 h and from 












































































models for all subjects. The differences demonstrate that the multiplicative 
model is preferred over the additive model in 8 out of 9 subjects. If we aggregate 
the data of all 9 subjects in order to study the average time course of cortisol, 
we find strong support for the multiplicative model (Table 1, Figure S2). That 
the multiplicative model is the strongly preferred model does not mean that the 
additive model does not fit the data well. The residual sum of squares over the 
108 available data-points for this model is also relatively low. For the average 
subject the mean deviation between predicted and raw values of cortisol is 
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Figure 2: Circadian (A) and 
masking (B) component 
of cortisol regulation. The 
thin lines represent the 
estimated components per 
individual and the thick lines 
represents the estimated 
components across the 
average raw cortisol levels 
of the 9 subjects. Zero 
on the x-axis denotes the 
endogenous phase of the 
first cortisol measurement 
taken after the first night of 
short (6.5 h) sleep during 
the forced desynchrony 
experiment, corresponding 











































































































































































Raw data Predicted Clock timehh:mm
Figure 3: Average 
and individual cortisol 
concentrations with 
fit during the forced 
desynchrony experiment. 
Raw cortisol data is 
indicated by the connected 
line. The fit (multiplication) 
is represented by the white 
dots, and correspond to 
the actual time points of 
saliva collection. Grey areas 
indicate the periods during 




1.31 nmol L-1 in the additive model vs. 1.01 nmol L-1 in the multiplicative model. 
We conclude that the cortisol concentrations are best fitted by a multiplication 
of a ‘circadian’ component and a ‘wake’ (masking) component across subjects 
(Figure 3A). Also for the individual subjects we find accurate fits (Figure 3B). 
The circadian modulation of the cortisol response shown in Figure 2A, runs 
from a minimum value of 0.36 to a maximum of 1.89, so there is a five-fold 
change in sensitivity across the circadian cycle, with peak sensitivity on average 
at 8:42 h under normal circumstances (during the forced desynchrony 
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experiment the cortisol peak occurred at 8:58 h clock time on day two; after 
≈33 h of free run which caused an estimated 16 min delay of the melatonin 
rhythm). On top of that, the data show a decline in masking induced cortisol 
production across the subjective day. Maximum and minimum cortisol values of 
the average masking component were 13.32 nmol L-1and 5.04 nmol L-1 
respectively, showing a decline of a factor 2.6 (Figure 2B). This decline, 
however, is of a different nature as compared to the circadian decline: the 
circadian decline shows a difference in sensitivity of the system as a function of 
circadian phase, meaning that the same stimulus (e.g. waking up) when applied 
at a different phase will lead to a different response. The decline in masking 
across the waking interval, in contrast, results from changes in stimulation to 
release cortisol. For instance, waking up elicits a stronger cortisol response than 
having dinner. Note that these estimates are from an experimental setting in 
which subjects were well informed about the fact that the investigators 
Figure 4: Awakening cortisol response at different circadian phases.  Mean (±SEM) cortisol 
concentrations of all 9 subjects over the first 90 min after waking up at the different circadian phases 
during the forced desynchrony experiment. Wake up times represent actual clock time and occurred 
during the experiment in the following order: 4:30 h (squares), 00:30 h (diamond), 20:30 h (triangles 
down), 16:30 h (triangles up), 12:30 h (stars), 8:30 h (circles). Because the subjects’ internal rhythms 
free ran within the forced desynchrony (see text), the corresponding clock times under natural 
circumstances are predicted at: 4:17 h (squares), 00:07 h (diamond), 19:57 h (triangles down), 15:47 h 
(triangles up), 11:37 h (stars), 7:27 h (circles), as calculated from the average subject’s melatonin period.
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determined bed times. Subjects did not experience much stress. Specific effects 
of prominent stressors were not tested in this study. Yet, extrapolating our 
results to a more stressful situation, we expect cortisol responses to become 
extremely elevated at the peak circadian phase (on average at 8:42 h clock time 
under normal circumstances), and to be severely dampened at the nadir (around 
clock time 22:28 h under normal circumstances; during the forced desynchrony 
experiment the nadir occurred at 22:51 h clock time on day two; after ≈47 h
of free run which caused an estimated 23 min delay of the melatonin rhythm). 
These effects can be especially relevant in a shift work environment where people 
are awake during a large part of their circadian peak in cortisol production.
Under these conditions, work-related stress, light exposure (Scheer & Buijs, 
1999), intake of protein (Gibson et al., 1999), and intake of glucose (Gonzalez-
Bono et al., 2002) are predicted to trigger a much higher cortisol response than 
at other circadian phases. This may have consequences for accurate decision 
making since cortisol levels show an inverted U-shape relationship with memory 
consolidation and a negative relationship with memory retrieval (Belanoff et al., 
2001). Indeed shift-work has been positively associated with occupational 
accidents (Folkard & Lombardi, 2006; Suzuki et al., 2004). 
Insight in the circadian regulation of cortisol production is important for 
another reason. Cortisol has been linked to various health problems, including 
mental health issues; higher levels of cortisol have been associated with obesity 
Table 1. Tau of the individual melatonin rhythms and the residual sum of squares (RSS) of the 








AIC multiplication – 
AIC addition
1 1449 563.32 883.45 -48.60
2 1447 1078.72 1818.70 -56.41
3 1449 1680.42 1749.92 -4.38
4 1457 254.36 565.52 -86.29
5 1452 524.36 996.14 -69.30
6 1454 1708.66 1768.90 -3.74
7 1447 337.54 509.93 -44.56
8 1454 266.46 335.44 -24.86
9 1460 500.13 499.98 0.03
Across all subjects 1452 181.98 307.74 -56.74
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(Rosmond et al., 1998), cardiovascular disease (Girod & Brotman, 2004; 
Whitworth et al., 2005), and depression (Cowen, 2010). Moreover, high 
cortisol levels during pregnancy resulted in decreased cognitive abilities of the 
children born from these pregnancies (Bergman et al., 2010). Cortisol also 
regulates insulin secretion and is suggested to be responsible for the normal 
circadian pattern of glucose tolerance (Plat et al., 1996). Night shift-work 
is associated with elevated long-term cortisol release, as measured from hair 
samples (Manenschijn et al., 2011). Cortisol may therefore be a link to health 
problems experienced by shift-workers; they also experience higher risks of 
obesity (Karlsson et al., 2001), diabetes (Morikawa et al., 2005), cardiovascular 
disease (Bøggild & Knutsson, 1999; Vyas et al., 2012) and depression (Glass 
& Fujimoto, 1994; Scott et al., 1997). Health of shift-workers may improve 
when stress is reduced at times when the clock produces high stress sensitivity. 
Extreme early and late chronotypes (Roenneberg et al., 2003) suffer from social 
jetlag (Wittmann et al., 2006), the difference between their circadian timing 
and the social and working hours imposed by society. Waking up out of phase 
can have consequences for the height of the awakening cortisol response. The 
degree of social jetlag is associated with obesity (Roenneberg et al., 2012) and 
we predict that abnormal cortisol regulation may be a factor contributing to 
this relationship.
The circadian rhythm in glucocorticoids secretion/production results from a 
dual control of the adrenal cortex (Engeland & Arnhold, 2005). At the one 
hand increased adrenal sensitivity to adrenocorticotropic hormone (ACTH) 
is mediated via splanchnic neuronal innervation of the adrenal gland, which 
is controlled by the master clock, suprachiasmatic nucleus (SCN), via a 
polysynaptic connection (Engeland & Arnhold, 2005; Kalsbeek et al., 2012; 
Ulrich-Lai et al., 2006). Indeed administration of a set amount of ACTH 
results in different levels of cortisol release at different circadian phases in rats 
(Kaneko et al., 1981) and capuchin monkeys (Torres-Farfan et al., 2008). In 
humans, circadian modulation to adrenal sensitivity was not found at ACTH 
dosages in the physiological range (Dickstein et al., 1997), but was found with 
pharmacological dosages (Dickstein et al., 1991). Recent animal experiments 
also suggest SCN control via the splanchnic nerve of adrenal sensitivity to 
ACTH. Rats (in 11:11 LD) and golden hamsters (constant light) show 
splitting behaviour of their circadian activity and physiology, and also show 
dissociated rhythms of glucocorticoid release from ACTH, suggesting SCN 
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regulation of glucocorticoid release independent of ACTH (Lilley et al., 2012; 
Wotus et al., 2013). Moreover these rhythms are attenuated by disrupting the 
nerve connection between the SCN and the adrenal, i.e. splanchnicectomy 
(Ishida et al., 2005; Ulrich-Lai et al., 2006; Wotus et al., 2013). The other 
pathway towards circadian rhythms in ACTH has been interpreted to result 
from direct output from the SCN (Cascio et al., 1987; Engeland & Arnhold, 
2005). If the SCN simply stimulates ACTH release in a direct manner, we 
expect the SCN to generate a set rhythm of ACTH release each circadian 
cycle. Variation in for example stress levels would add cortisol to this fixed 
circadian component. However, we find a multiplicative relationship between 
the masking and circadian component of cortisol regulation. This suggests 
that the SCN regulates sensitivity of the route (Kalsbeek et al., 2012) from 
masking/stress signals to ACTH. For example we predict that the amplitude 
of the circadian rhythm in ACTH release is higher under stressful conditions. 
Circadian modulation of the sensitivity of the stress-to-ACTH route generates 
larger amplitude differences in cortisol at higher stress levels, contrary to an 
additive model of cortisol regulation. These predictions require further testing 
in separate experiments. A multiplicative model also fits better to the reported 
synergy between the neuronal activation of the adrenal gland and ACTH 
(Bornstein et al., 2008). The multiplicative relationship between the masking 
and circadian component of cortisol regulation is in line with circadian 
modulation of the sensitivity to produce cortisol upon a stimulus.
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Figure S1: Individual melatonin profiles.
Individual melatonin concentrations are indicated by the white dots. Individual tau’s (see Table 1) is 
plotted by the black line. Grey areas indicate periods of darkness during which the subjects were 
instructed to sleep. White areas indicate periods of wakefulness (< 10 lux). First day: hourly saliva 
collection from 19:00 – 1:00 h and every two hours from 1:00 – 9:00 h. Subjects were instructed to 
sleep from 00:00 – 9:00 h. Upon waking up subjects were free to go home (indicated by the asterisk) 
but returned to the lab the same evening and 3 saliva samples were collected at 22:00 h, 23:00 h and 
00:00 h. Subjects had a normal night of sleep from 0:00 – 8:30 h. The forced desynchrony protocol 
started upon waking up. The last subjective day was extended by an extra 2 hours (additional saliva 
collection at 23:00 h). Subjects were instructed to go to bed at 00:00 h, but saliva collection was con-
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Figure S2: Model fits of the multiplicative and additive model.
Scatter plots of the predicted values of the multiplicative and the additive model against the raw data 
using the average cortisol levels across all subjects. The diagonal line is the x equals y line, at which 
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In onze huidige 24 uur maatschappij zijn er steeds meer mensen wakker op 
tijdstippen waarop ons lichaam liever zou willen slapen. Werken tijdens de 
nacht, laat opblijven ’s nachts voor een feest, vroeg opstaan in de ochtend voor 
werk, of door tijdzones vliegen, is veelvoorkomend gedrag dat in conflict staat 
met onze lichamelijke voorkeur voor slaap/waak verdeling over de 24 uur. Onze 
biologische klok in de hersenen, op tijd gezet door lichtinformatie van met 
name de zon, regelt onze 24 uurs ritmiek in fysiologie en gedrag. Het kan dus 
zijn dat je lichaam gereed gemaakt wordt om te slapen, maar het midden op de 
dag is omdat je net van Amsterdam naar New York gevlogen bent. Individuele 
verschillen in afstemming en periode van de biologische klok zorgen er voor 
dat mensen verschillen in de tijd dat zij het liefst slapen of opstaan. Dit maakt 
bepaalde mensen minder of meer geschikt voor werk op bepaalde tijdstippen 
van de dag. Niet iedereen zal werken in nachtdienst of in de vroege ochtend 
kunnen verdragen. Hierdoor zullen veel mensen kiezen voor werk dat 
uitgevoerd wordt op tijdstippen die het beste passen bij hun voorkeur voor de 
tijdstippen waarop zij wakker willen zijn.
Desalniettemin zijn er veel mensen die in nachtdiensten werken of 
doordeweeks vroeger op moeten staan dan zij zouden willen. Wakker zijn 
op momenten waarop men liever zou slapen kan gevolgen hebben voor de 
alertheid, iets wat de kans op fouten en op ongelukken verhoogt. Met behulp 
van licht kan de alertheid worden verhoogd. Met name blauw licht, licht met 
een korte golflengte, is effectief in het verhogen van een gevoel van activatie 
en het verminderen van slaperigheid. Vooral tijdens werken in de nacht kan 
licht een belangrijke rol spelen in het wakker en alert houden van mensen. 
Hierdoor kan de productiviteit hoger komen te liggen en vermindert de kans 
op ongelukken/fouten veroorzaakt door vermoeidheid. 
Echter, blootstelling aan licht tijdens de nacht verstoort ook de nachtelijke 
fysiologie (zie hoofdstuk 2). ‘s Nachts is de temperatuur van de huid 
bijvoorbeeld hoger dan overdag. Een warme huid hangt samen met 
verhoogde gevoelens van slaperigheid en verminderde gevoelens van activiteit. 
Blootstelling aan licht tijdens de nacht verlaagt deze hogere huidtemperatuur 
en verhoogt de alertheid. Een ander voorbeeld van verstoring van de nachtelijke 
Samenvatting
131
fysiologie door licht is de aanmaak van melatonine. Melatonine is een hormoon 
dat alleen ’s nachts wordt aangemaakt en mede hierdoor informatie geeft over 
de tijd van de dag aan de rest van het lichaam. Licht, met name blauw licht, 
tijdens de nacht onderdrukt de aanmaak van melatonine. Deze verstoring in de 
melatonine huishouding wordt in verband gebracht met een verhoogd risico 
op (onder andere) kanker, met name in mensen die langdurig in nachtdiensten 
werken. Er zijn grote verschillen tussen mensen in de mate waarin melatonine 
onderdrukt wordt door licht (zie hoofdstuk 3). Als we weten wie gevoelig 
zijn voor melatonine-onderdrukking onder invloed van licht kunnen we 
mogelijk beter vaststellen welke personen geschikter zijn voor nachtdienst. 
Het verminderen van de hoeveelheid blauw licht tijdens de nacht is ook een 
mogelijke interventie. ’s Nachts wakker blijven onder geel/oranje licht blijkt het 
melatonine profiel inderdaad ongemoeid te laten (zie hoofdstuk 2).
Vroeg opstaan kan soms even moeilijk zijn als wakker blijven tijdens de 
nacht. Toch verschillen mensen hier sterk in, en kan 7 uur ’s ochtends voor 
de een veel vroeger aanvoelen dan voor de ander. Bij de één is het lichaam 
zich al aan het voorbereiden op de wakkere periode en wordt snel een goed 
functioneringsniveau bereikt. Anderen hebben soms wel meer dan een uur 
nodig om zich volledig wakker te voelen in de ochtend (zie hoofdstuk 4). De 
mensen die ’s ochtends moeite hebben met opstaan, hebben baat bij het zichzelf 
blootstellen aan licht in de ochtend, zelfs wanneer iemand op dat moment 
nog slaapt (hoofdstuk 4). Tijdens de ochtend, vlak voor het ontwaken begint 
het hormoon cortisol langzaam te stijgen. Direct na het ontwaken bereikt 
de cortisolconcentratie een piekwaarde. Deze ochtend cortisol piek geeft 
aan dat de wakkere periode van de dag is begonnen. De precieze rol van deze 
zogenaamde ochtend cortisol piek is nog niet helemaal duidelijk. De aanmaak 
van cortisol is een nauwkeurig samenspel tussen opdrachten gegeven door de 
biologische klok en stimulatie van buitenaf, zoals wakker worden, maar ook het 
ervaren van stress. Verhoogde spiegels van cortisol worden in verband gebracht 
met een scala aan ziektebeelden. Disregulatie van cortisol tijdens werken in de 
nacht zou dus mogelijk kunnen bijdragen aan de verhoogde gezondheidsrisico’s 




In de twee samengevoegde studies omschreven in dit hoofdstuk is onderzocht 
of werken in de nacht onder geel licht, waarbij blauw licht uit wit licht gefilterd 
wordt (short-wavelength attenuated polychromatic white light), de nachtelijke 
fysiologie minder verstoort dan werken onder volledig wit licht (full-spectrum 
light). De twee licht condities werden hiertoe vergeleken met een donkere 
controle conditie (dim light). Daarnaast is bekeken wat de gevolgen van 
deze licht condities zijn voor alertheid, slaperigheid en presteren op taken 
tijdens de nacht. De melatonine aanmaak bleek zo goed als onverstoord in 
geel licht: het betrof een onderdrukking van 6% vergeleken met de donkere 
controle tegenover 45% onderdrukking onder volledig wit licht. Ook de 
huidtemperatuur (DPG) was net zo warm in geel licht als in het donker, 
terwijl onder wit licht de huidtemperatuur aanzienlijk lager lag. Dus zowel 
melatonine als huidtemperatuur bleven met behulp van geel licht tijdens de 
nacht onverstoord. Een hoge huidtemperatuur kan echter gevolgen hebben 
voor de alertheid. In overeenstemming met eerder onderzoek vonden we 
namelijk dat er een samenhang is tussen huidtemperatuur en slaperigheid 
en alertheid. Hoe hoger de huidtemperatuur hoe slaperiger en minder alert 
iemand zich voelt. Interessant is dat deze samenhang niet werd gevonden tussen 
slaperigheid/alertheid en melatonine. Dit bevestigt het idee dat melatonine 
geen ‘slaaphormoon’ is, maar een hormoon dat de tijd van de dag aangeeft. 
Hoofdstuk 3
Uit de studie omschreven in hoofdstuk 2 bleek dat er grote verschillen tussen 
mensen bestaan in de mate waarin hun melatonine onderdrukt wordt onder 
invloed van licht. In hoofdstuk 3 is bekeken in hoeverre deze verschillen 
tussen mensen op cellulair niveau verklaard kunnen worden. Melatonine 
wordt aangemaakt in cellen van de pijnappelklier in de hersenen, maar direct 
mechanistisch onderzoek aan deze cellen bij mensen is niet mogelijk. Echter 
omdat alle cellen in iemands lichaam gemaakt worden op basis van hetzelfde 
DNA, kan tot op zekere hoogte een andere lichaamscel vergeleken worden 
met een pijnappelkliercel. In deze studie is bekeken hoe de activiteit van 
melatonine producerende cellen in de pijnappelklier onder invloed van het 
onderdrukkende signaal van licht (vastgesteld door melatonine concentratie in 
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het speeksel) samenhangt met de mate waarin een huidcel opgekweekt vanuit 
een biopt geactiveerd kan worden, via dezelfde moleculaire route die ook in 
de pijnappelkliercel betrokken is bij melatonine onderdrukking. Hieruit bleek 
dat er een relatie bestaat tussen de kracht waarmee pijnappelkliercellen en 
huidcellen een opdracht verwerkten. De proefpersonen verschilden in de kracht 
waarmee een signaal op moleculair niveau verwerkt werd in hun huidcellen. 
Wanneer een persoon cellen bevatte die een opdracht krachtiger konden 
uitvoeren bleek deze persoon minder verstoord te raken door de remmende 
werking van licht op de nachtelijke melatonine productie. Melatonine aanmaak 
bleef dan relatief hoog ondanks blootstelling aan licht. Dit resultaat suggereert 
dat huidcellen gebruikt kunnen worden om processen in de hersenen op 
moleculair niveau te bestuderen. Mogelijk kan het ook worden gebruikt om 
informatie te verkrijgen over individuele verschillen in melatonine huishouding 
en misschien zelfs om te bepalen hoe geschikt een bepaald individu is om in 
nachtdienst te werken.
hypothese
Het resultaat beschreven in hoofdstuk 3 heeft geleid tot het vormen een 
hypothese die een paradox in de werking van licht bij winterdepressie kan 
verklaren. Mensen met winterdepressie laten een relatief hoge mate van 
melatonine onderdrukking zien wanneer zij aan licht worden blootgesteld. 
Dit suggereert een hoge mate van gevoeligheid voor licht. Echter, juist het 
geven van extra licht, zoals bij licht therapie, is effectief in de behandeling van 
winterdepressie, hetgeen een verminderde gevoeligheid voor licht suggereert. 
Een verklaring hiervoor zou kunnen liggen in een verminderde gevoeligheid 
van lichaamscellen in mensen met winterdepressie. Lichtblootstelling tijdens 
de nacht zorgt ervoor dat de opdracht aan pijnappelkliercellen om melatonine 
aan te maken verminderd wordt. Wanneer iemand pijnappelkliercellen bevat 
die minder krachtig zijn, zal een vermindering in de opdracht een grote 
daling in productie van melatonine tot gevolg hebben. Licht therapie werkt 
waarschijnlijk via het hormoon serotonine. Serotonine-aanmaak kan verhoogd 
worden door extra licht. Wanneer zenuwcellen die serotonine aanmaken 
minder krachtig zijn, kan juist extra licht ervoor zorgen dat de aanmaak van 
serotonine verhoogd wordt. Dit kan dus mogelijk verklaren waarom mensen 
met winterdepressie en verhoogde melatonine suppressie laten zien en baat 




Na het ontwaken met behulp van een wekker, zoals dat op werkdagen vaak het 
geval is, hebben veel mensen nog geruime tijd nodig om zich volledig wakker te 
voelen. In deze studie hebben proefpersonen deelgenomen die aangaven meer 
dan een uur nodig te hebben na het opstaan in de ochtend om zich volledig 
wakker te voelen. We onderzochten of deze periode verkort kon worden door 
iemand tijdens de laatste 30 minuten van de slaap aan kunstmatig opkomend 
ochtendlicht bloot te stellen (tot een maximale lichtintensiteit van 300 lux), 
door middel van de Philips Wake-up Light. Slaperigheid was lager en gevoel 
van activiteit hoger tijdens de 1,5 uur na het opstaan wanneer proefpersonen 
blootgesteld waren aan opkomend ochtendlicht vergeleken met geen licht tijdens 
de laatste 30 minuten van de slaap. Huidtemperatuur, gemeten rondom de torso 
(Proximal) en van handen en voeten (Distal), en het verschil hiertussen (Distal-
to-proximal skin temperature gradient: DPG) daalde sneller na het opstaan bij 
gebruik van opkomend ochtendlicht tijdens de slaap. In het elektro-encefalogram 
(EEG) van proefpersonen onder opkomend ochtendlicht waren ook meer korte 
slaaponderbrekingen te zien mogelijk wijzend op een meer geleidelijke manier 
van wakker worden. 
Net als in hoofdstuk 2, werd in deze studie een samenhang gevonden tussen 
huidtemperatuur en slaperigheid en gevoel van activiteit. Hoe lager de 
temperatuur hoe minder slaperig en hoe actiever de proefpersoon zich voelde. 
Al is bekend uit de literatuur dat licht in de ochtend de ochtend cortisol piek 
kan verhogen, werd er in deze studie geen hogere ochtend cortisol piek gemeten 
na het gebruik van gesimuleerd opkomend ochtendlicht. Dit kan komen omdat 
deze experimentele conditie vergeleken werd met een controle waarbij na het 
opstaan het licht ook aan was. Dit kan ervoor gezorgd hebben dat een eventueel 
effect van gesimuleerd ochtendlicht op de ochtend cortisol piek niet gemeten 
kon worden. Het is echter nog maar de vraag in hoeverre cortisol in de ochtend 
bijdraagt aan het proces van zich wakker voelen, cortisol liet namelijk een 
negatief verband zien met gevoelens van activiteit. 
Hoofdstuk 5
In de studie omschreven in dit hoofdstuk werd onderzocht hoe de biologische 
klok de aanmaak van cortisol reguleert. Zoals beschreven in hoofdstuk 4 wordt 
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cortisol vlak na het wakker worden in de ochtend in hoge mate aangemaakt. 
Een piek in cortisol wordt gemiddeld 30 minuten na het wakker gemeten. De 
aanmaak van de ochtend cortisol piek wordt net als de voorkeur voor tijd van 
ontwaken gereguleerd door de biologische klok. Omdat de biologische klok 
ook de timing van slapen en waken bepaalt, is het moeilijk om de effecten van 
de biologische klok los te koppelen van de effecten die slaap of waak zouden 
kunnen hebben op cortisol spiegels gedurende de dag en nacht. Om enkel 
het effect van de biologische klok vast te kunnen stellen moet de slaap op 
verschillende fasen van de biologische klok plaatsvinden. Om dit voor elkaar 
te krijgen zonder dat een proefpersoon dit bemerkt, verblijven proefpersonen 
in een zogenaamde tijdvrije ruimte. In deze ruimte zijn geen indicatoren van 
de tijd van de dag aanwezig, er komt geen zonlicht binnen en het licht blijft 
gedimd. Zonder de invloed van licht tikt de biologische klok in zijn eigen 
tempo. Proefpersonen verbleven een week in deze gedimde tijdvrije ruimte en 
leefden niet op een 24 uur dag, maar op een dag van 20 uur. Zij sliepen 6,5 uur 
per ‘nacht’ en waren 13,5 uur wakker per ‘dag’. Iedere ‘dag’ gingen zij dus 4 uur 
vroeger naar bed dan de dag ervoor terwijl de biologische klok de fysiologische 
processen in het lichaam gemiddeld nog steeds om de ongeveer 24 uur liet 
plaatsvinden. Hierdoor kon cortisol gemeten worden op verschillende fasen van 
de biologische klok, in combinatie met verschillende fasen van het slaap-waak 
ritme. Uit dit onderzoek komt duidelijk naar voren dat de ochtend cortisol piek 
het hoogst wordt na ontwaken in de natuurlijke ochtend. Bij ontwaken op ieder 
ander moment van de dag ligt de ochtend cortisol piek lager en verdwijnt zelfs 
helemaal bij ontwaken in de late middag en avond. Verder bleek dat de regulatie 
van cortisolaanmaak over de hele dag het beste verklaard kan worden met een 
model dat een vermenigvuldiging maakt van het effect van de biologische klok en 
effecten door het ontwaken en waken zelf. Dit past bij recent dierexperimenteel 
onderzoek waar gevonden is dat de gevoeligheid van de bijnierschors, die 
cortisol produceert, gereguleerd wordt door de biologische klok via een directe 
zenuwverbinding. Dit heeft belangrijke consequenties voor stress of ontwaken 
buiten de natuurlijke periode. Op sommige fasen van de biologische klok, in 
de ‘natuurlijke’ vroege ochtend, kan dit door deze mutiplicatieve relatie leiden 
tot extreme cortisol niveaus. Dit zou mogelijk verhoogde lange termijn cortisol 
spiegels van mensen in nachtdiensten kunnen verklaren en negatieve effecten van 
nachtdiensten op gezondheid zouden mogelijk verminderd kunnen worden als 




In dit proefschrift zijn effecten van licht op alertheid, prestatie en fysiologie 
onderzocht en is er gekeken hoe de biologische klok deze processen in mensen 
reguleert. Verschillende onderzoekingen zijn uitgevoerd om meer inzicht 
te verkrijgen in de effecten van lichtblootstelling tijdens de nacht en in de 
ochtend, hoe de effecten van licht verklaard kunnen worden op cellulair niveau, 
maar ook hoe fysiologische processen aangestuurd worden door de biologische 
klok wanneer deze geen informatie over tijd van de dag door middel van licht 
ontvangt. Kleine aanpassingen van bijvoorbeeld licht in onze werkomgeving 
(hoofdstuk 2), of in de huiselijke omgeving (hoofdstuk 4) en rekening houden 
met onze interne biologische klok (hoofdstuk 5) en individuele verschillen in 
aangrenzende fysiologie (hoofdstuk 3) bieden perspectief om in onze 24 uur 
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